===== phenotype 39=================================================================
proportion of pts: 0.231257437525
lambda: 15956.1484073
----------------------------------------
DiabetesNutritional deficienciesDisorders of lipoid metabolismDisorders of fluid, electrolyte, and acid-base balanceAnemiasDisorders of the eye and adnexaChronic rheumatic heart diseaseHypertensive diseaseIschemic heart diseaseOther forms of heart diseaseDiseases of arteries, arterioles, and capillariesOther diseases of respiratory systemNephritis, nephrotic syndrome, and nephrosisArthropathies and related disordersRheumatism, excluding the backGeneral symptomsSymptoms involving skin and other integumentary tissueSymptoms involving cardiovascular systemSymptoms involving respiratory system and other chest symptomsOther and unspecified effects of external causesRange name na----------------------------------------
Adrenergic alpha-1 Receptor Antagonists
Adrenergic alpha-2 Receptor Agonists
Adrenergic beta-1 Receptor Antagonists
Adrenergic beta-Antagonists
Analgesics, Non-Narcotic
Angiotensin II Type 1 Receptor Blockers
Anti-Allergic Agents
Anti-Asthmatic Agents
Anti-Bacterial Agents
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Antihypertensive Agents
Antioxidants
Bone Density Conservation Agents
Cardiotonic Agents
Cyclooxygenase Inhibitors
Enzyme Inhibitors
GABA-A Receptor Agonists
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Mineralocorticoid Receptor Antagonists
NA
Narcotics
Proton Pump Inhibitors
Purinergic P1 Receptor Antagonists
Rodenticides
Sodium Chloride Symporter Inhibitors
Sodium Potassium Chloride Symporter Inhibitors
Sympatholytics
Topoisomerase II Inhibitors
Tubulin Modulators
Vasodilator Agents
Vitamin B Complex
Vitamins
===== phenotype 25=================================================================
proportion of pts: 0.146370487902
lambda: 14248.325935
----------------------------------------
Other bacterial diseasesMalignant neoplasm of breastDiabetesDisorders of fluid, electrolyte, and acid-base balanceOverweight, obesity and other hyperalimentationNaDrug dependenceOperations on the cardiovascular systemDisorders of the peripheral nervous systemHypertensive diseaseIschemic heart diseaseOther forms of heart diseaseCerebrovascular diseaseDiseases of veins and lymphatics, and other diseases of circulatory systemOther diseases of respiratory systemOther diseases of urinary systemOther diseases of skin and subcutaneous tissueArthropathies and related disordersDorsopathiesRheumatism, excluding the backOsteopathies, chondropathies, and acquired musculoskeletal deformitiesCongenital anomaliesOperations on the musculoskeletal systemGeneral symptomsSymptoms involving cardiovascular systemSymptoms involving respiratory system and other chest symptomsNonspecific findings on examination of bloodNonspecific abnormal findings on radiological and other examination of body structureAbnormal results of function studiesIll-defined and unknown causes of morbidity and mortalityOperations on the integumentary systemMiscellaneous diagnostic and therapeutic proceduresComplications of surgical and medical care, not elsewhere classifiedRange name na----------------------------------------
14-alpha Demethylase Inhibitors
Adrenergic beta-1 Receptor Antagonists
Adrenergic beta-2 Receptor Agonists
Analgesics, Non-Narcotic
Anesthetics, Local
Antacids
Anti-Allergic Agents
Anti-Anxiety Agents
Anti-Bacterial Agents
Anti-Infective Agents, Local
Anti-Infective Agents, Urinary
Anti-Inflammatory Agents, Non-Steroidal
Antidepressive Agents, Second-Generation
Antihypertensive Agents
Antimalarials
Antimanic Agents
Antineoplastic Agents, Alkylating
Antineoplastic Agents, Hormonal
Antitussive Agents
Cardiotonic Agents
Cathartics
Cyclooxygenase Inhibitors
Dopamine Antagonists
Emollients
Enzyme Inhibitors
Fibrinolytic Agents
GABA-A Receptor Agonists
Histamine H1 Antagonists
Histamine H2 Antagonists
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypoglycemic Agents
Leprostatic Agents
Myeloablative Agonists
NA
Narcotics
Proton Pump Inhibitors
Purinergic P1 Receptor Antagonists
Rodenticides
Serotonin Uptake Inhibitors
Sodium Potassium Chloride Symporter Inhibitors
Surface-Active Agents
Sweetening Agents
Topoisomerase II Inhibitors
Tubulin Modulators
Vasodilator Agents
Vitamins
Voltage-Gated Sodium Channel Blockers
===== phenotype 31=================================================================
proportion of pts: 0.150337167791
lambda: 13809.0347135
----------------------------------------
Other bacterial diseasesMycosesMalignant neoplasm of digestive organs and peritoneumSecondary malignant neoplasm of lymph nodes, digestive system and other specified sitesDisorders of fluid, electrolyte, and acid-base balanceAnemiasCoagulation or hemorrhagic diseasesOrganic psychotic conditionsOther psychosesDrug dependenceHereditary and degenerative diseases of the central nervous systemOther disorders of the central nervous systemDisorders of the peripheral nervous systemIschemic heart diseaseOther forms of heart diseaseCerebrovascular diseaseDiseases of arteries, arterioles, and capillariesPneumonia and influenzaOther diseases of respiratory systemLiverNephritis, nephrotic syndrome, and nephrosisOther diseases of urinary systemDorsopathiesRheumatism, excluding the backOsteopathies, chondropathies, and acquired musculoskeletal deformitiesGeneral symptomsNaSymptoms involving nervous and musculoskeletal systemsSymptoms involving skin and other integumentary tissueSymptoms involving head and neckSymptoms involving respiratory system and other chest symptomsSymptoms involving digestive systemSymptoms involving urinary systemIll-defined and unknown causes of morbidity and mortalityFracturesMiscellaneous diagnostic and therapeutic proceduresOther and unspecified effects of external causesRange name na----------------------------------------
5-alpha Reductase Inhibitors
Adrenergic alpha-1 Receptor Antagonists
Adrenergic beta-1 Receptor Antagonists
Adrenergic beta-2 Receptor Agonists
Analgesics, Non-Narcotic
Antacids
Anti-Allergic Agents
Anti-Anxiety Agents
Anti-Bacterial Agents
Antidepressive Agents, Second-Generation
Antidiarrheals
Antimanic Agents
Antineoplastic Agents, Alkylating
Antineoplastic Agents, Hormonal
Cardiotonic Agents
Cathartics
Cholinergic Antagonists
Cyclooxygenase Inhibitors
Dopamine Antagonists
Enzyme Inhibitors
Explosive Agents
Fibrinolytic Agents
Gasotransmitters
Gastrointestinal Agents
Histamine H1 Antagonists
Histamine H1 Antagonists, Non-Sedating
Histamine H2 Antagonists
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Mineralocorticoid Receptor Antagonists
Muscarinic Antagonists
Myeloablative Agonists
NA
Narcotics
Neuroprotective Agents
Nootropic Agents
Proton Pump Inhibitors
Purinergic P2Y Receptor Antagonists
Rodenticides
Sodium Potassium Chloride Symporter Inhibitors
Surface-Active Agents
Sympatholytics
Topoisomerase II Inhibitors
Tranquilizing Agents
Vasodilator Agents
Vitamin B Complex
Vitamins
Voltage-Gated Sodium Channel Blockers
===== phenotype 28=================================================================
proportion of pts: 0.243950813169
lambda: 12654.8124235
----------------------------------------
Benign neoplasm of other parts of digestive systemDisorders of lipoid metabolismOrganic sleep disordersDisorders of the eye and adnexaDiseases of the ear and mastoid processHypertensive diseaseAcute respiratory infectionsOther diseases of the upper respiratory tractDiseases of esophagus, stomach, and duodenumOther diseases of intestines and peritoneumArthropathies and related disordersSymptoms involving head and neckSymptoms involving cardiovascular systemSymptoms involving respiratory system and other chest symptomsOther symptoms involving abdomen and pelvisNonspecific findings on examination of bloodRange name na----------------------------------------
14-alpha Demethylase Inhibitors
Analgesics, Non-Narcotic
Angiotensin II Type 1 Receptor Blockers
Anti-Allergic Agents
Anti-Asthmatic Agents
Anti-Bacterial Agents
Anti-Inflammatory Agents
Antidepressive Agents, Second-Generation
Antihypertensive Agents
Antineoplastic Agents, Hormonal
Bone Density Conservation Agents
Cardiotonic Agents
Cyclooxygenase Inhibitors
Estrogens
Expectorants
GABA Modulators
GABA-A Receptor Agonists
Glucocorticoids
Histamine H1 Antagonists, Non-Sedating
Histamine H2 Antagonists
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypolipidemic Agents
Leukotriene Antagonists
NA
Nasal Decongestants
Nucleic Acid Synthesis Inhibitors
Proton Pump Inhibitors
Purinergic P1 Receptor Antagonists
Sodium Chloride Symporter Inhibitors
Topoisomerase II Inhibitors
Vasodilator Agents
Vitamins
===== phenotype 15=================================================================
proportion of pts: 0.226497421658
lambda: 12500.9908177
----------------------------------------
Disorders of thyroid glandDisorders of lipoid metabolismDisorders of the eye and adnexaDiseases of the ear and mastoid processHypertensive diseaseIschemic heart diseaseCerebrovascular diseaseDiseases of arteries, arterioles, and capillariesArthropathies and related disordersDorsopathiesRheumatism, excluding the backOsteopathies, chondropathies, and acquired musculoskeletal deformitiesGeneral symptomsSymptoms involving skin and other integumentary tissueSymptoms involving head and neckSymptoms involving respiratory system and other chest symptomsRange name na----------------------------------------
Adrenergic alpha-1 Receptor Antagonists
Adrenergic beta-1 Receptor Antagonists
Analgesics, Non-Narcotic
Angiotensin II Type 1 Receptor Blockers
Antacids
Anti-Allergic Agents
Anti-Bacterial Agents
Anti-Inflammatory Agents
Antihypertensive Agents
Antimalarials
Bone Density Conservation Agents
Cardiotonic Agents
Cathartics
Cyclooxygenase Inhibitors
Explosive Agents
GABA Modulators
Histamine H1 Antagonists, Non-Sedating
Hydroxymethylglutaryl-CoA Reductase Inhibitors
NA
Proton Pump Inhibitors
Purinergic P2Y Receptor Antagonists
Rodenticides
Sodium Chloride Symporter Inhibitors
Surface-Active Agents
Tissue Adhesives
Vasodilator Agents
Vitamins
===== phenotype 27=================================================================
proportion of pts: 0.169773899246
lambda: 12177.3962834
----------------------------------------
Malignant neoplasm of badder, kidney and other urinary organsOperations on the nose, mouth, and pharynxBenign neoplasm of other parts of digestive systemDisorders of lipoid metabolismDisorders of mineral metabolismDisorders of fluid, electrolyte, and acid-base balanceAnemiasOperations on the respiratory systemOperations on the cardiovascular systemHypertensive diseaseIschemic heart diseaseOther forms of heart diseaseDiseases of arteries, arterioles, and capillariesDiseases of veins and lymphatics, and other diseases of circulatory systemOther diseases of respiratory systemDiseases of esophagus, stomach, and duodenumHernia of abdominal cavityOther diseases of intestines and peritoneumNephritis, nephrotic syndrome, and nephrosisOther diseases of urinary systemDiseases of male genital organsSymptoms involving cardiovascular systemSymptoms involving respiratory system and other chest symptomsSymptoms involving digestive systemOther symptoms involving abdomen and pelvisNonspecific findings on examination of bloodNonspecific abnormal findings on radiological and other examination of body structureAbnormal results of function studiesIll-defined and unknown causes of morbidity and mortalityMiscellaneous diagnostic and therapeutic proceduresOther and unspecified effects of external causesRange name na----------------------------------------
5-alpha Reductase Inhibitors
Adrenergic alpha-1 Receptor Antagonists
Adrenergic beta-1 Receptor Antagonists
Analgesics, Non-Narcotic
Anesthetics, Intravenous
Angiotensin II Type 1 Receptor Blockers
Anti-Anxiety Agents
Anti-Bacterial Agents
Antineoplastic Agents, Alkylating
Bone Density Conservation Agents
Cardiotonic Agents
Cathartics
Chelating Agents
Cyclooxygenase Inhibitors
Emollients
Enzyme Inhibitors
Expectorants
Explosive Agents
Fibrinolytic Agents
GABA Modulators
Histamine H2 Antagonists
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypoglycemic Agents
Leprostatic Agents
Mineralocorticoid Receptor Antagonists
NA
Narcotics
Nucleic Acid Synthesis Inhibitors
Proton Pump Inhibitors
Purinergic P2Y Receptor Antagonists
Rodenticides
Sclerosing Solutions
Sodium Potassium Chloride Symporter Inhibitors
Surface-Active Agents
Sweetening Agents
Tissue Adhesives
Vasoconstrictor Agents
Vasodilator Agents
===== phenotype 26=================================================================
proportion of pts: 0.163427211424
lambda: 12011.0319349
----------------------------------------
Intestinal infectious diseasesOther bacterial diseasesDiseases of other endocrine glandsDisorders of fluid, electrolyte, and acid-base balanceOther and unspecified disorders of metabolismOverweight, obesity and other hyperalimentationOther immune disordersCoagulation or hemorrhagic diseasesOther diseases of the bloodNeurotic, personality, nonpsychotic disordersOrganic sleep disordersHereditary and degenerative diseases of the central nervous systemPainIschemic heart diseaseDiseases of pulmonary circulationOther forms of heart diseaseDiseases of veins and lymphatics, and other diseases of circulatory systemChronic obstructive pulmonary disease and allied conditionsOther diseases of respiratory systemOther diseases of intestines and peritoneumNephritis, nephrotic syndrome, and nephrosisInfections of skin and subcutaneous tissueGeneral symptomsSymptoms involving nervous and musculoskeletal systemsSymptoms involving skin and other integumentary tissueSymptoms concerning nutrition, metabolism, and developmentSymptoms involving cardiovascular systemSymptoms involving respiratory system and other chest symptomsSymptoms involving digestive systemSymptoms involving urinary systemNonspecific findings on examination of bloodIll-defined and unknown causes of morbidity and mortalityOperations on the integumentary systemCertain traumatic complications and unspecified injuriesOther and unspecified effects of external causesComplications of surgical and medical care, not elsewhere classified----------------------------------------
14-alpha Demethylase Inhibitors
Adrenergic alpha-1 Receptor Antagonists
Adrenergic alpha-2 Receptor Agonists
Adrenergic beta-1 Receptor Antagonists
Adrenergic beta-2 Receptor Agonists
Analgesics, Non-Narcotic
Anesthetics, Intravenous
Angiotensin II Type 1 Receptor Blockers
Antacids
Anti-Allergic Agents
Anti-Anxiety Agents
Anti-Bacterial Agents
Anti-Inflammatory Agents
Antidepressive Agents, Second-Generation
Antimanic Agents
Antineoplastic Agents, Hormonal
Bone Density Conservation Agents
Cholinergic Antagonists
Cyclooxygenase Inhibitors
Dopamine Agonists
Dopamine Uptake Inhibitors
Explosive Agents
GABA Modulators
Glucocorticoids
Histamine H1 Antagonists, Non-Sedating
Histamine H2 Antagonists
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypoglycemic Agents
Immunosuppressive Agents
Mineralocorticoid Receptor Antagonists
Myeloablative Agonists
NA
Narcotics
Nucleic Acid Synthesis Inhibitors
Parasympatholytics
Proton Pump Inhibitors
Purinergic P1 Receptor Antagonists
Radiation-Sensitizing Agents
Rodenticides
Sodium Chloride Symporter Inhibitors
Sodium Potassium Chloride Symporter Inhibitors
Surface-Active Agents
Sweetening Agents
Topoisomerase II Inhibitors
Trace Elements
Tranquilizing Agents
Tubulin Modulators
Vasoconstrictor Agents
Vasodilator Agents
Voltage-Gated Sodium Channel Blockers
===== phenotype 37=================================================================
proportion of pts: 0.16858389528
lambda: 11819.9266439
----------------------------------------
Malignant neoplasm of male and female genital organsMalignant neoplasm of badder, kidney and other urinary organsSecondary malignant neoplasm of lymph nodes, digestive system and other specified sitesDisorders of thyroid glandAnemiasNaNeurotic, personality, nonpsychotic disordersPainHypertensive diseaseIschemic heart diseaseOperations on the digestive systemOther forms of heart diseaseDiseases of veins and lymphatics, and other diseases of circulatory systemDiseases of esophagus, stomach, and duodenumOther diseases of intestines and peritoneumOther diseases of urinary systemDiseases of male genital organsDorsopathiesRheumatism, excluding the backSymptoms involving nervous and musculoskeletal systemsSymptoms involving skin and other integumentary tissueSymptoms involving cardiovascular systemSymptoms involving respiratory system and other chest symptomsSymptoms involving digestive systemSymptoms involving urinary systemOther symptoms involving abdomen and pelvisIll-defined and unknown causes of morbidity and mortalityMiscellaneous diagnostic and therapeutic proceduresOpen woundSuperficial, contusion, crushing injuriesOther and unspecified effects of external causesComplications of surgical and medical care, not elsewhere classifiedRange name na----------------------------------------
Adrenergic alpha-1 Receptor Antagonists
Adrenergic beta-2 Receptor Agonists
Analgesics, Non-Narcotic
Antacids
Anti-Allergic Agents
Anti-Anxiety Agents
Anti-Bacterial Agents
Anti-Infective Agents, Urinary
Anti-Inflammatory Agents, Non-Steroidal
Antidepressive Agents, Second-Generation
Antidiarrheals
Antihypertensive Agents
Antimalarials
Antimanic Agents
Antitussive Agents
Bone Density Conservation Agents
Cathartics
Cyclooxygenase Inhibitors
Dopamine Antagonists
Estrogens
GABA Modulators
Gastrointestinal Agents
Glucocorticoids
Histamine H1 Antagonists
Histamine H1 Antagonists, Non-Sedating
Histamine H2 Antagonists
Immunosuppressive Agents
NA
Narcotics
Parasympatholytics
Proton Pump Inhibitors
Radiation-Sensitizing Agents
Rodenticides
Serotonin Uptake Inhibitors
Sodium Potassium Chloride Symporter Inhibitors
Surface-Active Agents
Topoisomerase II Inhibitors
Trace Elements
Tranquilizing Agents
Vasodilator Agents
Vitamins
Voltage-Gated Sodium Channel Blockers
===== phenotype 2=================================================================
proportion of pts: 0.213407378025
lambda: 11819.2724702
----------------------------------------
Other diseases due to viruses and chlamydiaeMalignant neoplasm of male and female genital organsBenign neoplasm of other parts of digestive systemDiabetesDisorders of lipoid metabolismGoutDisorders of fluid, electrolyte, and acid-base balanceOverweight, obesity and other hyperalimentationAnemiasOrganic sleep disordersDisorders of the peripheral nervous systemDisorders of the eye and adnexaHypertensive diseaseIschemic heart diseaseOther forms of heart diseaseAcute respiratory infectionsOther diseases of the upper respiratory tractPneumonia and influenzaOther diseases of respiratory systemDiseases of esophagus, stomach, and duodenumHernia of abdominal cavityOther diseases of intestines and peritoneumLiverGallbladderOther diseases of digestive systemNephritis, nephrotic syndrome, and nephrosisDiseases of male genital organsRheumatism, excluding the backSymptoms involving respiratory system and other chest symptomsSymptoms involving digestive systemOther symptoms involving abdomen and pelvisNonspecific findings on examination of urineRange name na----------------------------------------
Adrenergic alpha-1 Receptor Antagonists
Adrenergic beta-1 Receptor Antagonists
Adrenergic beta-2 Receptor Agonists
Anesthetics, Intravenous
Angiotensin II Type 1 Receptor Blockers
Antacids
Anti-Allergic Agents
Anti-Bacterial Agents
Anticholesteremic Agents
Antineoplastic Agents, Alkylating
Antineoplastic Agents, Hormonal
Antitussive Agents
Cardiotonic Agents
Cathartics
Chelating Agents
Coloring Agents
Cyclooxygenase Inhibitors
Dipeptidyl-Peptidase IV Inhibitors
Food Additives
Free Radical Scavengers
Histamine H2 Antagonists
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypoglycemic Agents
Hypolipidemic Agents
Immunosuppressive Agents
Indicators and Reagents
Mineralocorticoid Receptor Antagonists
NA
Phosphodiesterase 5 Inhibitors
Proton Pump Inhibitors
Sodium Chloride Symporter Inhibitors
Sodium Potassium Chloride Symporter Inhibitors
Topoisomerase II Inhibitors
Tubulin Modulators
Vasodilator Agents
Vitamins
===== phenotype 23=================================================================
proportion of pts: 0.263387544625
lambda: 11684.8378321
----------------------------------------
DiabetesNutritional deficienciesDisorders of lipoid metabolismNaOrganic sleep disordersHypertensive diseaseInfections of skin and subcutaneous tissueRheumatism, excluding the backGeneral symptomsSymptoms involving skin and other integumentary tissueSymptoms involving respiratory system and other chest symptomsNonspecific findings on examination of bloodRange name na----------------------------------------
14-alpha Demethylase Inhibitors
Adrenergic alpha-1 Receptor Antagonists
Adrenergic beta-1 Receptor Antagonists
Analgesics, Non-Narcotic
Angiotensin II Type 1 Receptor Blockers
Anti-Allergic Agents
Anti-Bacterial Agents
Antidepressive Agents, Second-Generation
Antihypertensive Agents
Antioxidants
Bone Density Conservation Agents
Cardiotonic Agents
Cyclooxygenase Inhibitors
Dipeptidyl-Peptidase IV Inhibitors
Histamine H1 Antagonists, Non-Sedating
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypoglycemic Agents
Hypolipidemic Agents
Immunosuppressive Agents
NA
Phosphodiesterase 5 Inhibitors
Proton Pump Inhibitors
Sodium Chloride Symporter Inhibitors
Tubulin Modulators
Vasodilator Agents
Vitamin B Complex
===== phenotype 43=================================================================
proportion of pts: 0.174930583102
lambda: 11597.2542995
----------------------------------------
MycosesDisorders of thyroid glandDiabetesDisorders of lipoid metabolismOverweight, obesity and other hyperalimentationDisorders of the peripheral nervous systemDisorders of the eye and adnexaDiseases of the ear and mastoid processHypertensive diseaseOther forms of heart diseaseAcute respiratory infectionsOther diseases of the upper respiratory tractPneumonia and influenzaChronic obstructive pulmonary disease and allied conditionsOther diseases of respiratory systemDiseases of esophagus, stomach, and duodenumOther diseases of urinary systemArthropathies and related disordersDorsopathiesRheumatism, excluding the backGeneral symptomsSymptoms involving skin and other integumentary tissueSymptoms involving respiratory system and other chest symptomsSymptoms involving urinary systemIll-defined and unknown causes of morbidity and mortalityRange name na----------------------------------------
5-alpha Reductase Inhibitors
Adrenergic alpha-2 Receptor Agonists
Adrenergic beta-2 Receptor Agonists
Analgesics, Non-Narcotic
Angiotensin II Type 1 Receptor Blockers
Anti-Allergic Agents
Anti-Asthmatic Agents
Anti-Bacterial Agents
Anticholesteremic Agents
Antimanic Agents
Antineoplastic Agents, Hormonal
Antitussive Agents
Bone Density Conservation Agents
Cardiotonic Agents
Cholinergic Antagonists
Cyclooxygenase 2 Inhibitors
Cyclooxygenase Inhibitors
Excitatory Amino Acid Antagonists
Expectorants
Glucocorticoids
Histamine H1 Antagonists, Non-Sedating
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypoglycemic Agents
Immunosuppressive Agents
Leukotriene Antagonists
NA
Neuroprotective Agents
Proton Pump Inhibitors
Serotonin Uptake Inhibitors
Sodium Chloride Symporter Inhibitors
Sodium Potassium Chloride Symporter Inhibitors
Sympathomimetics
Topoisomerase II Inhibitors
Tubulin Modulators
Vasoconstrictor Agents
Vasodilator Agents
===== phenotype 38=================================================================
proportion of pts: 0.202300674336
lambda: 11369.5762551
----------------------------------------
Disorders of thyroid glandDiabetesDisorders of lipoid metabolismDisorders of the peripheral nervous systemDisorders of the eye and adnexaDiseases of the ear and mastoid processHypertensive diseaseNephritis, nephrotic syndrome, and nephrosisArthropathies and related disordersDorsopathiesRheumatism, excluding the backOsteopathies, chondropathies, and acquired musculoskeletal deformitiesGeneral symptomsSymptoms involving skin and other integumentary tissueOpen woundSuperficial, contusion, crushing injuriesRange name na----------------------------------------
Adrenergic Uptake Inhibitors
Adrenergic alpha-1 Receptor Antagonists
Adrenergic beta-1 Receptor Antagonists
Analgesics, Non-Narcotic
Anesthetics, Local
Angiotensin II Type 1 Receptor Blockers
Anti-Allergic Agents
Anti-Bacterial Agents
Anti-Inflammatory Agents
Antihypertensive Agents
Antimanic Agents
Antineoplastic Agents, Alkylating
Antineoplastic Agents, Hormonal
Bone Density Conservation Agents
Cardiotonic Agents
Cyclooxygenase Inhibitors
GABA-A Receptor Agonists
Glucocorticoids
Histamine H1 Antagonists, Non-Sedating
Histamine H2 Antagonists
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypoglycemic Agents
Hypolipidemic Agents
NA
Narcotics
Nucleic Acid Synthesis Inhibitors
Proton Pump Inhibitors
Serotonin Uptake Inhibitors
Sodium Chloride Symporter Inhibitors
Sodium Potassium Chloride Symporter Inhibitors
Topoisomerase II Inhibitors
Tranquilizing Agents
Tubulin Modulators
Vasodilator Agents
Vitamin B Complex
Vitamins
===== phenotype 5=================================================================
proportion of pts: 0.20071400238
lambda: 11366.4376556
----------------------------------------
Malignant neoplasm of respiratory and intrathoracic organsMalignant neoplasm of skinOperations on the nose, mouth, and pharynxDisorders of lipoid metabolismOperations on the respiratory systemDrug dependenceOperations on the cardiovascular systemHypertensive diseaseIschemic heart diseaseOther forms of heart diseaseDiseases of arteries, arterioles, and capillariesPneumonia and influenzaChronic obstructive pulmonary disease and allied conditionsOther diseases of respiratory systemDiseases of esophagus, stomach, and duodenumHernia of abdominal cavityOperations on the musculoskeletal systemSymptoms involving cardiovascular systemSymptoms involving respiratory system and other chest symptomsMiscellaneous diagnostic and therapeutic proceduresOther and unspecified effects of external causesComplications of surgical and medical care, not elsewhere classifiedRange name na----------------------------------------
Adrenergic alpha-1 Receptor Antagonists
Adrenergic beta-1 Receptor Antagonists
Adrenergic beta-2 Receptor Agonists
Analgesics, Non-Narcotic
Angiotensin II Type 1 Receptor Blockers
Anti-Allergic Agents
Anti-Asthmatic Agents
Anti-Bacterial Agents
Antidepressive Agents, Second-Generation
Antihypertensive Agents
Antineoplastic Agents, Hormonal
Antioxidants
Bone Density Conservation Agents
Cardiotonic Agents
Cholinergic Antagonists
Cyclooxygenase Inhibitors
Explosive Agents
Free Radical Scavengers
GABA Modulators
GABA-A Receptor Agonists
Histamine H1 Antagonists, Non-Sedating
Hydroxymethylglutaryl-CoA Reductase Inhibitors
NA
Neuroprotective Agents
Nitric Oxide Donors
Nucleic Acid Synthesis Inhibitors
Proton Pump Inhibitors
Purinergic P1 Receptor Antagonists
Purinergic P2Y Receptor Antagonists
Sodium Chloride Symporter Inhibitors
Sodium Potassium Chloride Symporter Inhibitors
Sympathomimetics
Topoisomerase II Inhibitors
Vasodilator Agents
Vitamin B Complex
Vitamins
Voltage-Gated Sodium Channel Blockers
===== phenotype 40=================================================================
proportion of pts: 0.201904006347
lambda: 11344.1579165
----------------------------------------
Malignant neoplasm of breastDisorders of lipoid metabolismDisorders of the eye and adnexaHypertensive diseaseOther forms of heart diseaseAcute respiratory infectionsOther diseases of the upper respiratory tractDiseases of esophagus, stomach, and duodenumOther diseases of urinary systemDisorders of breastOther disorders of female genital tractInfections of skin and subcutaneous tissueArthropathies and related disordersRheumatism, excluding the backOsteopathies, chondropathies, and acquired musculoskeletal deformitiesGeneral symptomsSymptoms involving skin and other integumentary tissueSymptoms concerning nutrition, metabolism, and developmentSymptoms involving cardiovascular systemSymptoms involving respiratory system and other chest symptomsSymptoms involving urinary systemNonspecific abnormal findings on radiological and other examination of body structureOther and nonspecific abnormal cytological, histological, immunological and dna test findingsRange name na----------------------------------------
Adrenergic beta-1 Receptor Antagonists
Analgesics, Non-Narcotic
Angiotensin II Type 1 Receptor Blockers
Antacids
Anti-Allergic Agents
Anti-Bacterial Agents
Anti-Infective Agents, Urinary
Antidepressive Agents, Second-Generation
Antihypertensive Agents
Antimalarials
Antimanic Agents
Aromatase Inhibitors
Bone Density Conservation Agents
Cardiotonic Agents
Cyclooxygenase 2 Inhibitors
Cyclooxygenase Inhibitors
Enzyme Inhibitors
Estrogens
Food Additives
GABA Modulators
Histamine H1 Antagonists, Non-Sedating
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Immunosuppressive Agents
Myeloablative Agonists
NA
Narcotics
Proton Pump Inhibitors
Rodenticides
Sodium Chloride Symporter Inhibitors
Sodium Potassium Chloride Symporter Inhibitors
Surface-Active Agents
Vasodilator Agents
Vitamin B Complex
Vitamins
Voltage-Gated Sodium Channel Blockers
===== phenotype 21=================================================================
proportion of pts: 0.230067433558
lambda: 11342.7292836
----------------------------------------
Disorders of lipoid metabolismAnemiasNaOrganic sleep disordersDisorders of the peripheral nervous systemDiseases of the ear and mastoid processHypertensive diseaseIschemic heart diseaseAcute respiratory infectionsDiseases of esophagus, stomach, and duodenumOther diseases of intestines and peritoneumArthropathies and related disordersDorsopathiesRheumatism, excluding the backOsteopathies, chondropathies, and acquired musculoskeletal deformitiesGeneral symptomsSymptoms involving skin and other integumentary tissueSymptoms involving head and neckSymptoms involving respiratory system and other chest symptomsSymptoms involving digestive systemOther symptoms involving abdomen and pelvisNonspecific findings on examination of bloodOpen woundRange name na----------------------------------------
Adrenergic alpha-2 Receptor Agonists
Adrenergic beta-1 Receptor Antagonists
Analgesics, Non-Narcotic
Angiotensin II Type 1 Receptor Blockers
Anti-Allergic Agents
Anti-Asthmatic Agents
Anticholesteremic Agents
Antidepressive Agents, Second-Generation
Antihypertensive Agents
Cyclooxygenase 2 Inhibitors
Cyclooxygenase Inhibitors
Dopamine Agonists
Dopamine Uptake Inhibitors
Estrogens
GABA Modulators
GABA-A Receptor Agonists
Histamine H1 Antagonists, Non-Sedating
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Mineralocorticoid Receptor Antagonists
NA
Proton Pump Inhibitors
Serotonin Uptake Inhibitors
Sodium Chloride Symporter Inhibitors
Sodium Potassium Chloride Symporter Inhibitors
Vasodilator Agents
===== phenotype 22=================================================================
proportion of pts: 0.149940499802
lambda: 11150.9795789
----------------------------------------
Other bacterial diseasesNutritional deficienciesDisorders of fluid, electrolyte, and acid-base balanceAnemiasOther diseases of the bloodOrganic psychotic conditionsNaNeurotic, personality, nonpsychotic disordersHereditary and degenerative diseases of the central nervous systemPainOther disorders of the central nervous systemDisorders of the eye and adnexaDiseases of the ear and mastoid processHypertensive diseaseCerebrovascular diseaseDiseases of veins and lymphatics, and other diseases of circulatory systemDiseases of esophagus, stomach, and duodenumNoninfectious enteritis and colitisOther diseases of intestines and peritoneumOther diseases of digestive systemOther diseases of urinary systemDorsopathiesOsteopathies, chondropathies, and acquired musculoskeletal deformitiesCongenital anomaliesOperations on the musculoskeletal systemGeneral symptomsSymptoms involving nervous and musculoskeletal systemsSymptoms concerning nutrition, metabolism, and developmentSymptoms involving head and neckSymptoms involving respiratory system and other chest symptomsSymptoms involving digestive systemSymptoms involving urinary systemOther symptoms involving abdomen and pelvisNonspecific findings on examination of bloodNonspecific abnormal findings on radiological and other examination of body structureNaCertain traumatic complications and unspecified injuriesComplications of surgical and medical care, not elsewhere classifiedRange name na----------------------------------------
14-alpha Demethylase Inhibitors
Adrenergic Uptake Inhibitors
Adrenergic alpha-2 Receptor Agonists
Adrenergic beta-1 Receptor Antagonists
Analgesics, Non-Narcotic
Anesthetics, Intravenous
Angiotensin II Type 1 Receptor Blockers
Anti-Allergic Agents
Anti-Bacterial Agents
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Antidepressive Agents, Second-Generation
Antimanic Agents
Antioxidants
Bone Density Conservation Agents
Cardiotonic Agents
Cathartics
Cyclooxygenase Inhibitors
Dopamine Uptake Inhibitors
Estrogens
Explosive Agents
Fibrinolytic Agents
GABA Modulators
GABA-A Receptor Agonists
Gastrointestinal Agents
Histamine H1 Antagonists
Histamine H1 Antagonists, Non-Sedating
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypnotics and Sedatives
Hypoglycemic Agents
Hypolipidemic Agents
Muscarinic Antagonists
NA
Narcotics
Neuroprotective Agents
Nitric Oxide Donors
Nootropic Agents
Platelet Aggregation Inhibitors
Proton Pump Inhibitors
Purinergic P2Y Receptor Antagonists
Rodenticides
Serotonin Uptake Inhibitors
Sodium Chloride Symporter Inhibitors
Sodium Potassium Chloride Symporter Inhibitors
Surface-Active Agents
Topoisomerase II Inhibitors
Tubulin Modulators
Vasodilator Agents
Vitamin B Complex
===== phenotype 32=================================================================
proportion of pts: 0.22570408568
lambda: 11076.2915677
----------------------------------------
Disorders of thyroid glandNutritional deficienciesDisorders of lipoid metabolismNaNeurotic, personality, nonpsychotic disordersDrug dependenceOrganic sleep disordersDiseases of the ear and mastoid processHypertensive diseaseAcute respiratory infectionsOther diseases of the upper respiratory tractChronic obstructive pulmonary disease and allied conditionsOther diseases of urinary systemDiseases of male genital organsOther disorders of female genital tractOther inflammatory conditions of skin and subcutaneous tissueOther diseases of skin and subcutaneous tissueArthropathies and related disordersDorsopathiesRheumatism, excluding the backOsteopathies, chondropathies, and acquired musculoskeletal deformitiesGeneral symptomsSymptoms involving skin and other integumentary tissueSymptoms involving head and neckSymptoms involving respiratory system and other chest symptomsSymptoms involving digestive systemSymptoms involving urinary systemOther symptoms involving abdomen and pelvisNonspecific findings on examination of bloodNa----------------------------------------
Adrenergic Uptake Inhibitors
Adrenergic alpha-1 Receptor Antagonists
Adrenergic beta-2 Receptor Agonists
Analgesics, Non-Narcotic
Anti-Allergic Agents
Anti-Anxiety Agents
Anti-Asthmatic Agents
Anti-Bacterial Agents
Antimanic Agents
Antineoplastic Agents, Hormonal
Antitussive Agents
Calcium Channel Blockers
Cathartics
Cholinergic Antagonists
Cyclooxygenase 2 Inhibitors
Cyclooxygenase Inhibitors
Dopamine Uptake Inhibitors
Enzyme Inhibitors
Expectorants
GABA-A Receptor Agonists
Histamine H1 Antagonists, Non-Sedating
Histamine H2 Antagonists
Leukotriene Antagonists
Muscle Relaxants, Central
NA
Narcotics
Neuroprotective Agents
Parasympatholytics
Proton Pump Inhibitors
Purinergic P1 Receptor Antagonists
Serotonin Receptor Agonists
Surface-Active Agents
Sympathomimetics
Tranquilizing Agents
Vitamin B Complex
Voltage-Gated Sodium Channel Blockers
===== phenotype 8=================================================================
proportion of pts: 0.246727489092
lambda: 10999.0203472
----------------------------------------
MycosesBenign neoplasm of other parts of digestive systemBenign neoplasm of skinDiabetesDisorders of lipoid metabolismDisorders of the eye and adnexaHypertensive diseaseIschemic heart diseaseDiseases of arteries, arterioles, and capillariesDiseases of esophagus, stomach, and duodenumOther diseases of intestines and peritoneumDiseases of male genital organsOther diseases of skin and subcutaneous tissueArthropathies and related disordersDorsopathiesRheumatism, excluding the backOsteopathies, chondropathies, and acquired musculoskeletal deformitiesOther symptoms involving abdomen and pelvisNonspecific findings on examination of bloodRange name na----------------------------------------
Adrenergic beta-1 Receptor Antagonists
Analgesics, Non-Narcotic
Anti-Allergic Agents
Antihypertensive Agents
Antimalarials
Antioxidants
Bone Density Conservation Agents
Cardiotonic Agents
Cyclooxygenase 2 Inhibitors
Cyclooxygenase Inhibitors
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypoglycemic Agents
Hypolipidemic Agents
NA
Nucleic Acid Synthesis Inhibitors
Proton Pump Inhibitors
Sodium Chloride Symporter Inhibitors
Topoisomerase II Inhibitors
Trace Elements
Vasodilator Agents
Vitamin B Complex
Vitamins
===== phenotype 47=================================================================
proportion of pts: 0.155493851646
lambda: 10802.0257207
----------------------------------------
Operations on the nervous systemOther infectious and parasitic diseasesBenign neoplasm of eye, brain and other parts of nervous systemDisorders of thyroid glandDiabetesDisorders of lipoid metabolismOther psychosesDrug dependenceOrganic sleep disordersPainDisorders of the peripheral nervous systemHypertensive diseaseChronic obstructive pulmonary disease and allied conditionsDiseases of esophagus, stomach, and duodenumArthropathies and related disordersDorsopathiesRheumatism, excluding the backOsteopathies, chondropathies, and acquired musculoskeletal deformitiesOperations on the musculoskeletal systemSymptoms involving skin and other integumentary tissueSprains and strains of joints and adjacent musclesRange name na----------------------------------------
Adrenergic alpha-2 Receptor Agonists
Adrenergic beta-1 Receptor Antagonists
Analgesics, Non-Narcotic
Anesthetics, Intravenous
Anesthetics, Local
Angiotensin II Type 1 Receptor Blockers
Anti-Allergic Agents
Anti-Anxiety Agents
Anti-Bacterial Agents
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Antidepressive Agents, Second-Generation
Antihypertensive Agents
Antimanic Agents
Antineoplastic Agents, Hormonal
Antitussive Agents
Bone Density Conservation Agents
Cardiotonic Agents
Cathartics
Cyclooxygenase 2 Inhibitors
Cyclooxygenase Inhibitors
Enzyme Inhibitors
Fibrinolytic Agents
GABA Modulators
GABA-A Receptor Agonists
Histamine H1 Antagonists
Histamine H1 Antagonists, Non-Sedating
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypoglycemic Agents
Hypolipidemic Agents
Immunosuppressive Agents
NA
Narcotics
Proton Pump Inhibitors
Rodenticides
Sodium Chloride Symporter Inhibitors
Sodium Potassium Chloride Symporter Inhibitors
Surface-Active Agents
Topoisomerase II Inhibitors
Tranquilizing Agents
Vasodilator Agents
Vitamin B Complex
Vitamins
Voltage-Gated Sodium Channel Blockers
===== phenotype 30=================================================================
proportion of pts: 0.176120587069
lambda: 10768.964021
----------------------------------------
nanMalignant neoplasm of skinOperations on the nose, mouth, and pharynxDisorders of thyroid glandDisorders of lipoid metabolismGoutOrganic sleep disordersHereditary and degenerative diseases of the central nervous systemDisorders of the peripheral nervous systemDisorders of the eye and adnexaHypertensive diseaseOther forms of heart diseaseDiseases of veins and lymphatics, and other diseases of circulatory systemDiseases of esophagus, stomach, and duodenumOther diseases of urinary systemDiseases of male genital organsOther inflammatory conditions of skin and subcutaneous tissueOther diseases of skin and subcutaneous tissueArthropathies and related disordersDorsopathiesRheumatism, excluding the backOsteopathies, chondropathies, and acquired musculoskeletal deformitiesOperations on the musculoskeletal systemGeneral symptomsSymptoms involving respiratory system and other chest symptomsSymptoms involving urinary systemNonspecific findings on examination of bloodPoisoning by drugs, medicinal and biological substancesComplications of surgical and medical care, not elsewhere classifiedRange name na----------------------------------------
5-alpha Reductase Inhibitors
Adrenergic alpha-1 Receptor Antagonists
Adrenergic beta-1 Receptor Antagonists
Analgesics, Non-Narcotic
Anti-Allergic Agents
Anti-Bacterial Agents
Anti-Inflammatory Agents
Antidepressive Agents, Second-Generation
Antimanic Agents
Antineoplastic Agents, Hormonal
Bone Density Conservation Agents
Cardiotonic Agents
Cathartics
Cyclooxygenase Inhibitors
Fibrinolytic Agents
Free Radical Scavengers
GABA Modulators
GABA-A Receptor Agonists
Gastrointestinal Agents
Histamine H1 Antagonists
Histamine H1 Antagonists, Non-Sedating
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Mineralocorticoid Receptor Antagonists
Muscarinic Antagonists
NA
Parasympatholytics
Phosphodiesterase 5 Inhibitors
Preservatives, Pharmaceutical
Proton Pump Inhibitors
Rodenticides
Sodium Chloride Symporter Inhibitors
Sodium Potassium Chloride Symporter Inhibitors
Surface-Active Agents
Sympatholytics
Topoisomerase II Inhibitors
Tubulin Modulators
Vasodilator Agents
Voltage-Gated Sodium Channel Blockers
===== phenotype 7=================================================================
proportion of pts: 0.188020626735
lambda: 10765.5592257
----------------------------------------
Benign neoplasm of other parts of digestive systemCarcinoma in situ of breast & genitourinary systemDiabetesDisorders of lipoid metabolismGoutDisorders of fluid, electrolyte, and acid-base balanceOverweight, obesity and other hyperalimentationOther immune disordersNaNeurotic, personality, nonpsychotic disordersDrug dependenceOrganic sleep disordersOther disorders of the central nervous systemDisorders of the peripheral nervous systemHypertensive diseaseCerebrovascular diseaseDiseases of veins and lymphatics, and other diseases of circulatory systemPneumonia and influenzaDiseases of esophagus, stomach, and duodenumNephritis, nephrotic syndrome, and nephrosisOther diseases of urinary systemOther disorders of female genital tractDorsopathiesRheumatism, excluding the backGeneral symptomsSymptoms involving skin and other integumentary tissueSymptoms involving head and neckSymptoms involving cardiovascular systemSymptoms involving respiratory system and other chest symptomsSymptoms involving digestive systemNonspecific findings on examination of urineRange name na----------------------------------------
Adrenergic Uptake Inhibitors
Adrenergic alpha-2 Receptor Agonists
Adrenergic beta-1 Receptor Antagonists
Analgesics, Non-Narcotic
Angiotensin II Type 1 Receptor Blockers
Anti-Allergic Agents
Anti-Anxiety Agents
Anti-Bacterial Agents
Antidepressive Agents, Second-Generation
Antidiarrheals
Antihypertensive Agents
Antimanic Agents
Antiviral Agents
Bone Density Conservation Agents
Cardiotonic Agents
Cyclooxygenase Inhibitors
Dopamine Antagonists
Dopamine Uptake Inhibitors
Estrogens
Free Radical Scavengers
GABA Modulators
GABA-A Receptor Agonists
GABA-B Receptor Agonists
Histamine H1 Antagonists, Non-Sedating
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypoglycemic Agents
NA
Narcotics
Proton Pump Inhibitors
Serotonin Receptor Agonists
Serotonin Uptake Inhibitors
Sodium Chloride Symporter Inhibitors
Sodium Potassium Chloride Symporter Inhibitors
Surface-Active Agents
Topoisomerase II Inhibitors
Tranquilizing Agents
Tubulin Modulators
Vasodilator Agents
Vitamin B Complex
===== phenotype 44=================================================================
proportion of pts: 0.191590638635
lambda: 10670.2329867
----------------------------------------
Other bacterial diseasesMycosesBenign neoplasm of skinDisorders of thyroid glandDiabetesDisorders of lipoid metabolismDisorders of fluid, electrolyte, and acid-base balanceAnemiasDisorders of the peripheral nervous systemDisorders of the eye and adnexaHypertensive diseaseOther forms of heart diseaseNephritis, nephrotic syndrome, and nephrosisOther diseases of urinary systemOther disorders of female genital tractInfections of skin and subcutaneous tissueOther inflammatory conditions of skin and subcutaneous tissueOther diseases of skin and subcutaneous tissueDorsopathiesRheumatism, excluding the backGeneral symptomsSymptoms involving cardiovascular systemSymptoms involving respiratory system and other chest symptomsSymptoms involving digestive systemSymptoms involving urinary systemOther symptoms involving abdomen and pelvisNonspecific findings on examination of urineOther and unspecified effects of external causesRange name na----------------------------------------
14-alpha Demethylase Inhibitors
Adrenergic Uptake Inhibitors
Adrenergic beta-1 Receptor Antagonists
Analgesics, Non-Narcotic
Angiogenesis Inhibitors
Angiotensin II Type 1 Receptor Blockers
Antacids
Anti-Allergic Agents
Anti-Bacterial Agents
Anti-Infective Agents, Urinary
Anti-Inflammatory Agents
Antimalarials
Antimanic Agents
Antimutagenic Agents
Antitussive Agents
Bone Density Conservation Agents
Cardiotonic Agents
Chelating Agents
Cyclooxygenase Inhibitors
Dopamine Antagonists
Estrogens
Gastrointestinal Agents
Glucocorticoids
Hematinics
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypoglycemic Agents
Immunosuppressive Agents
Myeloablative Agonists
NA
Narcotics
Parasympatholytics
Proton Pump Inhibitors
Radiation-Sensitizing Agents
Rodenticides
Sodium Chloride Symporter Inhibitors
Sodium Potassium Chloride Symporter Inhibitors
Surface-Active Agents
Topoisomerase II Inhibitors
Vasodilator Agents
Vitamin B Complex
Voltage-Gated Sodium Channel Blockers
===== phenotype 19=================================================================
proportion of pts: 0.220150733836
lambda: 10650.612288
----------------------------------------
MycosesBenign neoplasm of skinDisorders of thyroid glandDisorders of lipoid metabolismNeurotic, personality, nonpsychotic disordersHereditary and degenerative diseases of the central nervous systemDisorders of the eye and adnexaHypertensive diseaseAcute respiratory infectionsOther disorders of female genital tractOther inflammatory conditions of skin and subcutaneous tissueOther diseases of skin and subcutaneous tissueArthropathies and related disordersDorsopathiesRheumatism, excluding the backGeneral symptomsSymptoms involving skin and other integumentary tissueSymptoms involving respiratory system and other chest symptomsNonspecific findings on examination of bloodRange name na----------------------------------------
14-alpha Demethylase Inhibitors
Analgesics, Non-Narcotic
Anti-Allergic Agents
Anti-Bacterial Agents
Anti-HIV Agents
Anti-Inflammatory Agents
Antidepressive Agents, Second-Generation
Antineoplastic Agents, Hormonal
Antioxidants
Bone Density Conservation Agents
Cyclooxygenase Inhibitors
Enzyme Inhibitors
Estrogens
Excitatory Amino Acid Antagonists
Food Additives
GABA Modulators
Gastrointestinal Agents
Glucocorticoids
Histamine H1 Antagonists
Histamine H1 Antagonists, Non-Sedating
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Immunosuppressive Agents
Keratolytic Agents
Mineralocorticoid Receptor Antagonists
NA
Neuroprotective Agents
Nucleic Acid Synthesis Inhibitors
Proton Pump Inhibitors
Purinergic P1 Receptor Antagonists
Serotonin Uptake Inhibitors
Sodium Chloride Symporter Inhibitors
Vasodilator Agents
Voltage-Gated Sodium Channel Blockers
===== phenotype 16=================================================================
proportion of pts: 0.232447441491
lambda: 10569.5655506
----------------------------------------
Malignant neoplasm of badder, kidney and other urinary organsDisorders of thyroid glandDiabetesOther disorders of pancreatic internal secretionDisorders of lipoid metabolismDisorders of the eye and adnexaHypertensive diseaseIschemic heart diseaseDiseases of esophagus, stomach, and duodenumOperations on the urinary systemOther diseases of urinary systemInflammatory disease of female pelvic organsOther disorders of female genital tractDorsopathiesGeneral symptomsSymptoms concerning nutrition, metabolism, and developmentSymptoms involving digestive systemSymptoms involving urinary systemOther symptoms involving abdomen and pelvisRange name na----------------------------------------
14-alpha Demethylase Inhibitors
Adrenergic Uptake Inhibitors
Adrenergic alpha-1 Receptor Antagonists
Adrenergic beta-1 Receptor Antagonists
Analgesics, Non-Narcotic
Angiotensin II Type 1 Receptor Blockers
Anti-Allergic Agents
Anti-Anxiety Agents
Anti-Bacterial Agents
Anti-Infective Agents, Urinary
Antifungal Agents
Antihypertensive Agents
Antimalarials
Bone Density Conservation Agents
Cyclooxygenase Inhibitors
Estrogens
GABA Modulators
GABA-A Receptor Agonists
Histamine H1 Antagonists, Non-Sedating
Histamine H2 Antagonists
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypoglycemic Agents
Hypolipidemic Agents
Muscarinic Antagonists
NA
Parasympatholytics
Proton Pump Inhibitors
Sodium Chloride Symporter Inhibitors
Sodium Potassium Chloride Symporter Inhibitors
Topoisomerase II Inhibitors
Tranquilizing Agents
Vasodilator Agents
Vitamins
===== phenotype 41=================================================================
proportion of pts: 0.154303847679
lambda: 10469.5574473
----------------------------------------
Other bacterial diseasesViral diseases accompanied by exanthemMalignant neoplasm of lymphatic and hematopoietic tissueDisorders of thyroid glandDiabetesDisorders of lipoid metabolismDisorders of plasma protein metabolismOther immune disordersAnemiasCoagulation or hemorrhagic diseasesOther diseases of the bloodPainDisorders of the eye and adnexaHypertensive diseaseIschemic heart diseaseOther forms of heart diseaseDiseases of veins and lymphatics, and other diseases of circulatory systemAcute respiratory infectionsOther diseases of the upper respiratory tractPneumonia and influenzaChronic obstructive pulmonary disease and allied conditionsOther diseases of respiratory systemDiseases of oral cavity, salivary glands, and jawsDiseases of esophagus, stomach, and duodenumDiseases of male genital organsInfections of skin and subcutaneous tissueOther inflammatory conditions of skin and subcutaneous tissueOther diseases of skin and subcutaneous tissueArthropathies and related disordersRheumatism, excluding the backOsteopathies, chondropathies, and acquired musculoskeletal deformitiesGeneral symptomsSymptoms involving skin and other integumentary tissueSymptoms involving head and neckSymptoms involving respiratory system and other chest symptomsSymptoms involving digestive systemMiscellaneous diagnostic and therapeutic proceduresRange name na----------------------------------------
14-alpha Demethylase Inhibitors
Adrenergic Uptake Inhibitors
Adrenergic alpha-1 Receptor Antagonists
Adrenergic beta-1 Receptor Antagonists
Adrenergic beta-2 Receptor Agonists
Analgesics, Non-Narcotic
Androgens
Angiogenesis Inhibitors
Anti-Allergic Agents
Anti-Anxiety Agents
Anti-Asthmatic Agents
Anti-Bacterial Agents
Antidepressive Agents, Second-Generation
Antimalarials
Antimanic Agents
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Antineoplastic Agents, Hormonal
Antioxidants
Antiviral Agents
Bone Density Conservation Agents
Cannabinoid Receptor Agonists
Cardiotonic Agents
Cathartics
Central Nervous System Depressants
Cyclooxygenase Inhibitors
Dopamine Antagonists
Enzyme Inhibitors
Fibrinolytic Agents
Flavoring Agents
Free Radical Scavengers
GABA Modulators
GABA-A Receptor Agonists
Gasotransmitters
Gastrointestinal Agents
Histamine Antagonists
Histamine H1 Antagonists
Histamine H1 Antagonists, Non-Sedating
Histamine H2 Antagonists
Hypnotics and Sedatives
Hypoglycemic Agents
Hypolipidemic Agents
Immunologic Factors
Indicators and Reagents
Keratolytic Agents
Myeloablative Agonists
NA
Narcotics
Proton Pump Inhibitors
Rodenticides
Sodium Potassium Chloride Symporter Inhibitors
Surface-Active Agents
Topoisomerase II Inhibitors
Trace Elements
Vasoconstrictor Agents
Vasodilator Agents
Vitamin B Complex
Vitamins
Voltage-Gated Sodium Channel Blockers
===== phenotype 49=================================================================
proportion of pts: 0.18286394288
lambda: 10353.2434527
----------------------------------------
Disorders of thyroid glandDiabetesDisorders of lipoid metabolismAnemiasOrganic sleep disordersDisorders of the peripheral nervous systemDisorders of the eye and adnexaHypertensive diseaseIschemic heart diseaseOther forms of heart diseaseCerebrovascular diseaseDiseases of arteries, arterioles, and capillariesAcute respiratory infectionsOther diseases of the upper respiratory tractOther diseases of respiratory systemDiseases of esophagus, stomach, and duodenumOther diseases of intestines and peritoneumNephritis, nephrotic syndrome, and nephrosisOther diseases of urinary systemOther inflammatory conditions of skin and subcutaneous tissueOther diseases of skin and subcutaneous tissueArthropathies and related disordersRheumatism, excluding the backGeneral symptomsSymptoms involving skin and other integumentary tissueSymptoms involving respiratory system and other chest symptomsSymptoms involving digestive systemSymptoms involving urinary systemOther symptoms involving abdomen and pelvisRange name na----------------------------------------
14-alpha Demethylase Inhibitors
Adrenergic alpha-1 Receptor Antagonists
Adrenergic beta-1 Receptor Antagonists
Analgesics, Non-Narcotic
Antidepressive Agents, Second-Generation
Antidiarrheals
Cathartics
Cyclooxygenase Inhibitors
Diuretics, Osmotic
Explosive Agents
GABA Modulators
Histamine H2 Antagonists
Hormones
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypoglycemic Agents
Hypolipidemic Agents
Immunosuppressive Agents
Narcotics
Nitric Oxide Donors
Proton Pump Inhibitors
Purinergic P2Y Receptor Antagonists
Sodium Potassium Chloride Symporter Inhibitors
Tissue Adhesives
===== phenotype 0=================================================================
proportion of pts: 0.201110670369
lambda: 10289.0201778
----------------------------------------
Other bacterial diseasesDiabetesDisorders of lipoid metabolismGoutOverweight, obesity and other hyperalimentationOrganic sleep disordersDisorders of the eye and adnexaHypertensive diseaseIschemic heart diseaseOther forms of heart diseaseInfections of skin and subcutaneous tissueArthropathies and related disordersDorsopathiesRheumatism, excluding the backOsteopathies, chondropathies, and acquired musculoskeletal deformitiesCongenital anomaliesGeneral symptomsSymptoms involving cardiovascular systemSymptoms involving respiratory system and other chest symptomsSymptoms involving digestive systemOther symptoms involving abdomen and pelvisNonspecific findings on examination of bloodAbnormal results of function studiesSprains and strains of joints and adjacent musclesRange name na----------------------------------------
Adrenergic Uptake Inhibitors
Adrenergic alpha-1 Receptor Antagonists
Adrenergic beta-1 Receptor Antagonists
Adrenergic beta-Antagonists
Analgesics, Non-Narcotic
Angiotensin II Type 1 Receptor Blockers
Anti-Allergic Agents
Anti-Asthmatic Agents
Anti-Bacterial Agents
Antimanic Agents
Antimutagenic Agents
Antineoplastic Agents, Hormonal
Bone Density Conservation Agents
Cardiotonic Agents
Cyclooxygenase Inhibitors
Emollients
Enzyme Inhibitors
Explosive Agents
Fatty Acid Synthesis Inhibitors
Fertility Agents, Female
Free Radical Scavengers
GABA Modulators
GABA-A Receptor Agonists
Histamine H1 Antagonists, Non-Sedating
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypoglycemic Agents
Immunosuppressive Agents
Mineralocorticoid Receptor Antagonists
NA
Neuroprotective Agents
Nucleic Acid Synthesis Inhibitors
Proton Pump Inhibitors
Purinergic P2Y Receptor Antagonists
Surface-Active Agents
Tranquilizing Agents
Tubulin Modulators
Vasodilator Agents
Voltage-Gated Sodium Channel Blockers
===== phenotype 48=================================================================
proportion of pts: 0.201904006347
lambda: 10156.2711948
----------------------------------------
Operations on the nose, mouth, and pharynxNutritional deficienciesDisorders of fluid, electrolyte, and acid-base balanceOther diseases of the bloodNaOther disorders of the central nervous systemDisorders of the peripheral nervous systemDisorders of the eye and adnexaHypertensive diseaseDiseases of arteries, arterioles, and capillariesAcute respiratory infectionsOther diseases of the upper respiratory tractPneumonia and influenzaChronic obstructive pulmonary disease and allied conditionsOther diseases of respiratory systemDiseases of esophagus, stomach, and duodenumNoninfectious enteritis and colitisOther diseases of intestines and peritoneumOther diseases of urinary systemOther disorders of female genital tractDorsopathiesRheumatism, excluding the backOsteopathies, chondropathies, and acquired musculoskeletal deformitiesGeneral symptomsSymptoms involving skin and other integumentary tissueSymptoms concerning nutrition, metabolism, and developmentSymptoms involving head and neckSymptoms involving cardiovascular systemSymptoms involving respiratory system and other chest symptomsSymptoms involving digestive systemSymptoms involving urinary systemOther symptoms involving abdomen and pelvisOther nonspecific abnormal findingsRange name na----------------------------------------
Adrenergic beta-2 Receptor Agonists
Analgesics, Non-Narcotic
Antacids
Anti-Allergic Agents
Anti-Bacterial Agents
Anti-Infective Agents, Urinary
Anti-Inflammatory Agents
Anti-Obesity Agents
Antidepressive Agents, Second-Generation
Antihypertensive Agents
Antineoplastic Agents, Alkylating
Antineoplastic Agents, Hormonal
Antioxidants
Bone Density Conservation Agents
Cardiotonic Agents
Cyclooxygenase Inhibitors
Dopamine Antagonists
Dopamine Uptake Inhibitors
Estrogens
Expectorants
GABA-A Receptor Agonists
Glucocorticoids
Histamine H1 Antagonists
Histamine H1 Antagonists, Non-Sedating
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Muscarinic Antagonists
NA
Nucleic Acid Synthesis Inhibitors
Parasympatholytics
Proton Pump Inhibitors
Radiation-Sensitizing Agents
Rodenticides
Sodium Chloride Symporter Inhibitors
Topoisomerase II Inhibitors
Vasodilator Agents
Vitamin B Complex
Vitamins
===== phenotype 35=================================================================
proportion of pts: 0.209440698136
lambda: 10122.4538194
----------------------------------------
Malignant neoplasm of male and female genital organsDisorders of thyroid glandDiabetesDisorders of lipoid metabolismAnemiasOrganic sleep disordersDisorders of the peripheral nervous systemDisorders of the eye and adnexaHypertensive diseaseIschemic heart diseaseOther forms of heart diseaseAcute respiratory infectionsOther diseases of respiratory systemDiseases of esophagus, stomach, and duodenumDiseases of male genital organsArthropathies and related disordersDorsopathiesRheumatism, excluding the backGeneral symptomsSymptoms involving respiratory system and other chest symptomsSymptoms involving urinary systemNonspecific findings on examination of bloodAbnormal results of function studiesRange name na----------------------------------------
5-alpha Reductase Inhibitors
Adrenergic beta-1 Receptor Antagonists
Antacids
Anti-Bacterial Agents
Anticholesteremic Agents
Antihypertensive Agents
Antimutagenic Agents
Bone Density Conservation Agents
Cardiotonic Agents
Central Nervous System Depressants
Cyclooxygenase Inhibitors
Estrogen Antagonists
Expectorants
Explosive Agents
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypolipidemic Agents
NA
Nootropic Agents
Phosphodiesterase 5 Inhibitors
Proton Pump Inhibitors
Radiation-Protective Agents
Rodenticides
Sodium Chloride Symporter Inhibitors
Topoisomerase II Inhibitors
Trace Elements
Vitamin B Complex
Vitamins
===== phenotype 45=================================================================
proportion of pts: 0.196747322491
lambda: 9935.04682899
----------------------------------------
MycosesMalignant neoplasm of digestive organs and peritoneumDiabetesDisorders of lipoid metabolismOverweight, obesity and other hyperalimentationOrganic sleep disordersDisorders of the eye and adnexaDiseases of the ear and mastoid processHypertensive diseaseDiseases of veins and lymphatics, and other diseases of circulatory systemAcute respiratory infectionsDiseases of oral cavity, salivary glands, and jawsOther diseases of intestines and peritoneumLiverOther diseases of urinary systemInfections of skin and subcutaneous tissueOther inflammatory conditions of skin and subcutaneous tissueOther diseases of skin and subcutaneous tissueArthropathies and related disordersDorsopathiesRheumatism, excluding the backGeneral symptomsSymptoms involving skin and other integumentary tissueSymptoms concerning nutrition, metabolism, and developmentSymptoms involving urinary systemOther symptoms involving abdomen and pelvisAbnormal results of function studiesOpen woundSuperficial, contusion, crushing injuriesNaRange name na----------------------------------------
14-alpha Demethylase Inhibitors
Adrenergic Uptake Inhibitors
Adrenergic alpha-2 Receptor Agonists
Analgesics, Non-Narcotic
Angiotensin II Type 1 Receptor Blockers
Anti-Allergic Agents
Anti-Bacterial Agents
Anti-Infective Agents, Urinary
Antihypertensive Agents
Antimalarials
Antimanic Agents
Antimetabolites, Antineoplastic
Bone Density Conservation Agents
Cardiotonic Agents
Cathartics
Cyclooxygenase Inhibitors
Dermatologic Agents
Enzyme Inhibitors
Glucocorticoids
Histamine H1 Antagonists, Non-Sedating
Histamine H2 Antagonists
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypoglycemic Agents
Hypolipidemic Agents
Immunosuppressive Agents
Mineralocorticoid Receptor Antagonists
NA
Nucleic Acid Synthesis Inhibitors
Parasympatholytics
Plant Growth Regulators
Sodium Chloride Symporter Inhibitors
Sodium Potassium Chloride Symporter Inhibitors
Surface-Active Agents
Topoisomerase II Inhibitors
Trypsin Inhibitors
Tubulin Modulators
Vasoconstrictor Agents
Vasodilator Agents
Vitamin B Complex
Vitamins
===== phenotype 33=================================================================
proportion of pts: 0.190797302658
lambda: 9879.34687676
----------------------------------------
Neoplasm of uncertain behavior of other sites & tissuesDisorders of thyroid glandNutritional deficienciesDisorders of mineral metabolismDisorders of fluid, electrolyte, and acid-base balanceOther immune disordersDisorders of the eye and adnexaDiseases of the ear and mastoid processHypertensive diseaseAcute respiratory infectionsDiseases of esophagus, stomach, and duodenumOther diseases of urinary systemOther inflammatory conditions of skin and subcutaneous tissueOther diseases of skin and subcutaneous tissueArthropathies and related disordersRheumatism, excluding the backOsteopathies, chondropathies, and acquired musculoskeletal deformitiesGeneral symptomsSymptoms involving respiratory system and other chest symptomsSymptoms involving urinary systemOther symptoms involving abdomen and pelvisOpen woundCertain traumatic complications and unspecified injuriesComplications of surgical and medical care, not elsewhere classifiedRange name na----------------------------------------
Adrenergic Uptake Inhibitors
Adrenergic alpha-2 Receptor Agonists
Adrenergic beta-1 Receptor Antagonists
Analgesics, Non-Narcotic
Antacids
Anti-Allergic Agents
Anti-Bacterial Agents
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Antihypertensive Agents
Antineoplastic Agents, Hormonal
Antitussive Agents
Bone Density Conservation Agents
Cyclooxygenase 2 Inhibitors
Cyclooxygenase Inhibitors
Emollients
Estrogens
GABA Modulators
Glucocorticoids
Histamine H1 Antagonists, Non-Sedating
Histamine H2 Antagonists
Immunosuppressive Agents
Muscarinic Agonists
NA
Narcotics
Proton Pump Inhibitors
Sodium Chloride Symporter Inhibitors
Topoisomerase II Inhibitors
Vasodilator Agents
Vitamin B Complex
Vitamins
===== phenotype 18=================================================================
proportion of pts: 0.199920666402
lambda: 9846.98315277
----------------------------------------
MycosesDiabetesDiseases of other endocrine glandsNutritional deficienciesDisorders of lipoid metabolismOverweight, obesity and other hyperalimentationOrganic sleep disordersDisorders of the peripheral nervous systemHypertensive diseaseOperations on the digestive systemDiseases of esophagus, stomach, and duodenumHernia of abdominal cavityOther diseases of intestines and peritoneumLiverGallbladderOther diseases of urinary systemDiseases of male genital organsOther inflammatory conditions of skin and subcutaneous tissueOther diseases of skin and subcutaneous tissueArthropathies and related disordersDorsopathiesRheumatism, excluding the backSymptoms involving skin and other integumentary tissueSymptoms involving respiratory system and other chest symptomsSymptoms involving digestive systemOther symptoms involving abdomen and pelvisNonspecific findings on examination of bloodAbnormal results of function studiesRange name na----------------------------------------
14-alpha Demethylase Inhibitors
Adrenergic Uptake Inhibitors
Adrenergic beta-1 Receptor Antagonists
Analgesics, Non-Narcotic
Androgens
Anti-Allergic Agents
Anti-Anxiety Agents
Anti-Bacterial Agents
Anti-Inflammatory Agents
Antifungal Agents
Antihypertensive Agents
Antimalarials
Antimanic Agents
Antineoplastic Agents, Alkylating
Bone Density Conservation Agents
Calcium Channel Blockers
Cardiotonic Agents
Cyclooxygenase Inhibitors
Dopamine Antagonists
Dopamine Uptake Inhibitors
GABA Modulators
GABA-A Receptor Agonists
Glucocorticoids
Hypoglycemic Agents
Hypolipidemic Agents
Immunosuppressive Agents
Muscle Relaxants, Central
NA
Narcotics
Parasympatholytics
Phosphodiesterase 5 Inhibitors
Proton Pump Inhibitors
Radiation-Protective Agents
Radiation-Sensitizing Agents
Serotonin Uptake Inhibitors
Sodium Chloride Symporter Inhibitors
Sweetening Agents
Vasodilator Agents
===== phenotype 34=================================================================
proportion of pts: 0.181673938913
lambda: 9799.90767211
----------------------------------------
Malignant neoplasm of skinNeoplasm of uncertain behavior of other sites & tissuesDisorders of thyroid glandNutritional deficienciesDisorders of lipoid metabolismAnemiasNeurotic, personality, nonpsychotic disordersOrganic sleep disordersHereditary and degenerative diseases of the central nervous systemDisorders of the peripheral nervous systemHypertensive diseaseOther forms of heart diseaseDiseases of esophagus, stomach, and duodenumHernia of abdominal cavityGallbladderNephritis, nephrotic syndrome, and nephrosisOther diseases of urinary systemOther inflammatory conditions of skin and subcutaneous tissueOther diseases of skin and subcutaneous tissueDorsopathiesRheumatism, excluding the backGeneral symptomsSymptoms involving cardiovascular systemSymptoms involving respiratory system and other chest symptomsSymptoms involving urinary systemOther symptoms involving abdomen and pelvisFracturesRange name na----------------------------------------
Adrenergic beta-1 Receptor Antagonists
Adrenergic beta-2 Receptor Agonists
Analgesics, Non-Narcotic
Antacids
Anti-Allergic Agents
Anti-Bacterial Agents
Antidepressive Agents, Second-Generation
Antimanic Agents
Antioxidants
Bone Density Conservation Agents
Calcium Channel Blockers
Cardiotonic Agents
Cathartics
Central Nervous System Depressants
Cholinergic Antagonists
Cyclooxygenase 2 Inhibitors
Cyclooxygenase Inhibitors
Dopamine Agonists
Dopamine Uptake Inhibitors
Enzyme Inhibitors
Food Additives
GABA Modulators
GABA-A Receptor Agonists
Gastrointestinal Agents
Histamine H1 Antagonists, Non-Sedating
Histamine H2 Antagonists
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Muscle Relaxants, Central
NA
Narcotics
Preservatives, Pharmaceutical
Proton Pump Inhibitors
Serotonin 5-HT1 Receptor Agonists
Serotonin Uptake Inhibitors
Surface-Active Agents
Topoisomerase II Inhibitors
Trace Elements
Tranquilizing Agents
Vasodilator Agents
Vitamin B Complex
Vitamins
Voltage-Gated Sodium Channel Blockers
===== phenotype 46=================================================================
proportion of pts: 0.20071400238
lambda: 9763.93805481
----------------------------------------
Lipoma and other benign neoplasm of connective and other soft tissueDiabetesDisorders of lipoid metabolismDisorders of mineral metabolismAnemiasNaDisorders of the eye and adnexaHypertensive diseaseAcute respiratory infectionsOther diseases of the upper respiratory tractDiseases of oral cavity, salivary glands, and jawsOther disorders of female genital tractArthropathies and related disordersDorsopathiesRheumatism, excluding the backOsteopathies, chondropathies, and acquired musculoskeletal deformitiesGeneral symptomsSymptoms involving head and neckSymptoms involving respiratory system and other chest symptomsSymptoms involving urinary systemRange name na----------------------------------------
Adrenergic alpha-2 Receptor Agonists
Analgesics, Non-Narcotic
Anti-Allergic Agents
Anti-Bacterial Agents
Antidepressive Agents, Second-Generation
Antihypertensive Agents
Antimanic Agents
Antineoplastic Agents, Hormonal
Antioxidants
Bone Density Conservation Agents
Cardiotonic Agents
Cyclooxygenase Inhibitors
Estrogens
GABA Modulators
GABA-A Receptor Agonists
Histamine H1 Antagonists, Non-Sedating
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypoglycemic Agents
Immunosuppressive Agents
Muscarinic Antagonists
Muscle Relaxants, Central
NA
Narcotics
Neuroprotective Agents
Nicotinic Agonists
Nucleic Acid Synthesis Inhibitors
Proton Pump Inhibitors
Purinergic P1 Receptor Antagonists
Radiation-Protective Agents
Serotonin 5-HT1 Receptor Agonists
Sodium Chloride Symporter Inhibitors
Trace Elements
Tranquilizing Agents
Tubulin Modulators
Vasodilator Agents
Vitamins
Voltage-Gated Sodium Channel Blockers
===== phenotype 12=================================================================
proportion of pts: 0.170170567235
lambda: 9457.60593457
----------------------------------------
Malignant neoplasm of digestive organs and peritoneumBenign neoplasm of other parts of digestive systemNeoplasms of unspecified natureNutritional deficienciesAnemiasHypertensive diseaseOperations on the digestive systemDiseases of veins and lymphatics, and other diseases of circulatory systemOther diseases of respiratory systemDiseases of esophagus, stomach, and duodenumHernia of abdominal cavityLiverOther diseases of digestive systemOther diseases of urinary systemArthropathies and related disordersDorsopathiesRheumatism, excluding the backCongenital anomaliesGeneral symptomsSymptoms involving skin and other integumentary tissueSymptoms involving cardiovascular systemSymptoms involving respiratory system and other chest symptomsSymptoms involving digestive systemOther symptoms involving abdomen and pelvisNonspecific findings on examination of bloodOther and nonspecific abnormal cytological, histological, immunological and dna test findingsOther nonspecific abnormal findingsRange name na----------------------------------------
Adrenergic alpha-1 Receptor Antagonists
Adrenergic alpha-2 Receptor Agonists
Adrenergic beta-1 Receptor Antagonists
Analgesics, Non-Narcotic
Anesthetics
Anesthetics, Intravenous
Angiotensin II Type 1 Receptor Blockers
Anti-Allergic Agents
Anti-Anxiety Agents
Anti-Bacterial Agents
Antidepressive Agents, Second-Generation
Antineoplastic Agents, Hormonal
Antioxidants
Bone Density Conservation Agents
Cardiotonic Agents
Cyclooxygenase Inhibitors
Enzyme Inhibitors
Explosive Agents
GABA Modulators
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Immunosuppressive Agents
Indicators and Reagents
NA
Narcotics
Nucleic Acid Synthesis Inhibitors
Parasympatholytics
Proton Pump Inhibitors
Sodium Chloride Symporter Inhibitors
Surface-Active Agents
Topoisomerase II Inhibitors
Trace Elements
Tubulin Modulators
Vasodilator Agents
Vitamin B Complex
Vitamins
===== phenotype 42=================================================================
proportion of pts: 0.181277270924
lambda: 9023.40244265
----------------------------------------
Disorders of thyroid glandDiabetesDisorders of lipoid metabolismGoutDisorders of mineral metabolismOverweight, obesity and other hyperalimentationAnemiasDiseases of the ear and mastoid processHypertensive diseaseIschemic heart diseaseDiseases of pulmonary circulationCerebrovascular diseaseDiseases of arteries, arterioles, and capillariesOther diseases of the upper respiratory tractChronic obstructive pulmonary disease and allied conditionsDiseases of esophagus, stomach, and duodenumNephritis, nephrotic syndrome, and nephrosisArthropathies and related disordersDorsopathiesSymptoms involving skin and other integumentary tissueSymptoms involving head and neckSymptoms involving respiratory system and other chest symptomsAbnormal results of function studiesRange name na----------------------------------------
Adrenergic alpha-1 Receptor Antagonists
Adrenergic alpha-2 Receptor Agonists
Adrenergic beta-1 Receptor Antagonists
Adrenergic beta-2 Receptor Agonists
Analgesics, Non-Narcotic
Angiotensin II Type 1 Receptor Blockers
Antacids
Anti-Allergic Agents
Anti-Asthmatic Agents
Anticholesteremic Agents
Antihypertensive Agents
Antimanic Agents
Antineoplastic Agents, Hormonal
Antioxidants
Bone Density Conservation Agents
Cathartics
Cholinergic Antagonists
Cyclooxygenase Inhibitors
Expectorants
Free Radical Scavengers
Histamine H1 Antagonists, Non-Sedating
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypoglycemic Agents
Leukotriene Antagonists
NA
Narcotics
Proton Pump Inhibitors
Sodium Chloride Symporter Inhibitors
Sodium Potassium Chloride Symporter Inhibitors
Surface-Active Agents
Sympathomimetics
Trace Elements
Tubulin Modulators
Vasoconstrictor Agents
Vasodilator Agents
Vitamin B Complex
Vitamins
===== phenotype 20=================================================================
proportion of pts: 0.17215390718
lambda: 9011.80497541
----------------------------------------
MycosesOperations on the nose, mouth, and pharynxDiabetesNutritional deficienciesDisorders of lipoid metabolismDisorders of fluid, electrolyte, and acid-base balanceAnemiasCoagulation or hemorrhagic diseasesOrganic psychotic conditionsDisorders of the eye and adnexaHypertensive diseaseIschemic heart diseaseOther forms of heart diseaseCerebrovascular diseaseDiseases of veins and lymphatics, and other diseases of circulatory systemHernia of abdominal cavityNephritis, nephrotic syndrome, and nephrosisInfections of skin and subcutaneous tissueOther inflammatory conditions of skin and subcutaneous tissueOther diseases of skin and subcutaneous tissueArthropathies and related disordersRheumatism, excluding the backOsteopathies, chondropathies, and acquired musculoskeletal deformitiesOperations on the musculoskeletal systemGeneral symptomsNaSymptoms involving respiratory system and other chest symptomsNonspecific findings on examination of bloodCertain traumatic complications and unspecified injuriesComplications of surgical and medical care, not elsewhere classifiedRange name na----------------------------------------
5-alpha Reductase Inhibitors
Adrenergic alpha-1 Receptor Antagonists
Adrenergic alpha-2 Receptor Agonists
Adrenergic beta-1 Receptor Antagonists
Analgesics, Non-Narcotic
Androgens
Anesthetics, Intravenous
Anesthetics, Local
Angiotensin II Type 1 Receptor Blockers
Anti-Allergic Agents
Anti-Asthmatic Agents
Anti-Bacterial Agents
Anti-Infective Agents, Local
Anti-Inflammatory Agents, Non-Steroidal
Antidepressive Agents, Second-Generation
Antifungal Agents
Antimalarials
Antimanic Agents
Antioxidants
Bone Density Conservation Agents
Cardiotonic Agents
Cyclooxygenase Inhibitors
Dipeptidyl-Peptidase IV Inhibitors
Excitatory Amino Acid Antagonists
Explosive Agents
GABA Modulators
Hematinics
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypoglycemic Agents
Immunosuppressive Agents
NA
Nitric Oxide Donors
Nootropic Agents
Proton Pump Inhibitors
Rodenticides
Serotonin Uptake Inhibitors
Sodium Chloride Symporter Inhibitors
Sodium Potassium Chloride Symporter Inhibitors
Surface-Active Agents
Sweetening Agents
Trace Elements
Tubulin Modulators
Vasodilator Agents
Vitamin B Complex
===== phenotype 4=================================================================
proportion of pts: 0.15787385958
lambda: 8963.90453163
----------------------------------------
MycosesMalignant neoplasm of male and female genital organsBenign neoplasm of other parts of digestive systemDisorders of thyroid glandDiabetesDisorders of lipoid metabolismOverweight, obesity and other hyperalimentationAnemiasCoagulation or hemorrhagic diseasesOrganic sleep disordersHereditary and degenerative diseases of the central nervous systemOther disorders of the central nervous systemOperations on the cardiovascular systemDisorders of the peripheral nervous systemDisorders of the eye and adnexaHypertensive diseaseIschemic heart diseaseOther forms of heart diseaseCerebrovascular diseaseDiseases of arteries, arterioles, and capillariesDiseases of veins and lymphatics, and other diseases of circulatory systemOther diseases of respiratory systemDiseases of esophagus, stomach, and duodenumOther diseases of intestines and peritoneumOther diseases of digestive systemOther diseases of skin and subcutaneous tissueArthropathies and related disordersDorsopathiesRheumatism, excluding the backOsteopathies, chondropathies, and acquired musculoskeletal deformitiesOperations on the musculoskeletal systemGeneral symptomsSymptoms involving nervous and musculoskeletal systemsSymptoms involving respiratory system and other chest symptomsMiscellaneous diagnostic and therapeutic proceduresRange name na----------------------------------------
Adrenergic alpha-2 Receptor Agonists
Analgesics, Non-Narcotic
Anesthetics, Intravenous
Anti-Allergic Agents
Anti-Bacterial Agents
Anti-Inflammatory Agents
Antifungal Agents
Antihypertensive Agents
Antimanic Agents
Bone Density Conservation Agents
Calcium Channel Blockers
Cardiotonic Agents
Cathartics
Cyclooxygenase 2 Inhibitors
Cyclooxygenase Inhibitors
Dopamine Agonists
Dopamine Uptake Inhibitors
Enzyme Inhibitors
Fibrinolytic Agents
GABA Modulators
Gastrointestinal Agents
Glucocorticoids
Histamine H1 Antagonists, Non-Sedating
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypoglycemic Agents
Immunosuppressive Agents
NA
Narcotics
Nucleic Acid Synthesis Inhibitors
Parasympatholytics
Plasma Substitutes
Proton Pump Inhibitors
Purinergic P2Y Receptor Antagonists
Reproductive Control Agents
Sodium Chloride Symporter Inhibitors
Surface-Active Agents
Tranquilizing Agents
Tubulin Modulators
Vasodilator Agents
Voltage-Gated Sodium Channel Blockers
===== phenotype 1=================================================================
proportion of pts: 0.217770725902
lambda: 8849.32057213
----------------------------------------
DiabetesNutritional deficienciesDisorders of lipoid metabolismNaNeurotic, personality, nonpsychotic disordersOrganic sleep disordersPainDisorders of the peripheral nervous systemDisorders of the eye and adnexaHypertensive diseaseIschemic heart diseaseOther forms of heart diseaseDiseases of arteries, arterioles, and capillariesOther diseases of urinary systemInfections of skin and subcutaneous tissueArthropathies and related disordersRheumatism, excluding the backOsteopathies, chondropathies, and acquired musculoskeletal deformitiesOperations on the musculoskeletal systemGeneral symptomsSymptoms involving respiratory system and other chest symptomsNonspecific findings on examination of bloodFracturesSprains and strains of joints and adjacent musclesOpen woundCertain traumatic complications and unspecified injuriesRange name na----------------------------------------
Adrenergic Uptake Inhibitors
Adrenergic alpha-2 Receptor Agonists
Analgesics, Non-Narcotic
Anesthetics, Local
Angiotensin II Type 1 Receptor Blockers
Antacids
Anti-Asthmatic Agents
Anti-Inflammatory Agents, Non-Steroidal
Antidepressive Agents, Second-Generation
Antimalarials
Antimanic Agents
Antineoplastic Agents, Hormonal
Antipsychotic Agents
Antiviral Agents
Bone Density Conservation Agents
Calcium Channel Blockers
Cyclooxygenase 2 Inhibitors
Dopamine Antagonists
Dopamine Uptake Inhibitors
Enzyme Inhibitors
Flavoring Agents
GABA Modulators
GABA-A Receptor Agonists
Hypnotics and Sedatives
Immunosuppressive Agents
Muscle Relaxants, Central
NA
Narcotics
Neuroprotective Agents
Nucleic Acid Synthesis Inhibitors
Sensory System Agents
Serotonin Uptake Inhibitors
Trace Elements
Tranquilizing Agents
Vitamin B Complex
Vitamins
Voltage-Gated Sodium Channel Blockers
===== phenotype 3=================================================================
proportion of pts: 0.150337167791
lambda: 8827.17878665
----------------------------------------
nanDiseases of other endocrine glandsDisorders of lipoid metabolismDrug dependenceOrganic sleep disordersOperations on the cardiovascular systemOperations on the hemic and lymphatic systemHypertensive diseaseIschemic heart diseaseOther forms of heart diseaseCerebrovascular diseaseDiseases of arteries, arterioles, and capillariesChronic obstructive pulmonary disease and allied conditionsOther diseases of urinary systemOperations on the male genital organsDiseases of male genital organsArthropathies and related disordersDorsopathiesCongenital anomaliesOperations on the musculoskeletal systemSymptoms involving cardiovascular systemSymptoms involving respiratory system and other chest symptomsMiscellaneous diagnostic and therapeutic proceduresRange name na----------------------------------------
Adrenergic alpha-1 Receptor Antagonists
Adrenergic alpha-2 Receptor Agonists
Adrenergic beta-1 Receptor Antagonists
Adrenergic beta-2 Receptor Agonists
Analgesics, Non-Narcotic
Anesthetics, Intravenous
Angiotensin II Type 1 Receptor Blockers
Anti-Allergic Agents
Anti-Asthmatic Agents
Anti-Bacterial Agents
Anticholesteremic Agents
Antidepressive Agents, Second-Generation
Antihypertensive Agents
Antineoplastic Agents, Alkylating
Antioxidants
Cardiotonic Agents
Cyclooxygenase Inhibitors
Explosive Agents
Histamine H1 Antagonists, Non-Sedating
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypoglycemic Agents
Hypolipidemic Agents
Muscarinic Antagonists
NA
Narcotics
Parasympatholytics
Phosphodiesterase 5 Inhibitors
Proton Pump Inhibitors
Purinergic P2Y Receptor Antagonists
Sodium Chloride Symporter Inhibitors
Tissue Adhesives
Tubulin Modulators
Vasodilator Agents
Vitamin B Complex
Voltage-Gated Sodium Channel Blockers
===== phenotype 6=================================================================
proportion of pts: 0.174137247124
lambda: 8724.33524441
----------------------------------------
Malignant neoplasm of breastNeoplasm of uncertain behavior of other sites & tissuesDisorders of thyroid glandDiabetesDiseases of other endocrine glandsNutritional deficienciesDisorders of lipoid metabolismDisorders of mineral metabolismOverweight, obesity and other hyperalimentationAnemiasNaOther psychosesNeurotic, personality, nonpsychotic disordersOrganic sleep disordersOther disorders of the central nervous systemDisorders of the peripheral nervous systemDisorders of the eye and adnexaHypertensive diseaseOther diseases of the upper respiratory tractChronic obstructive pulmonary disease and allied conditionsDiseases of esophagus, stomach, and duodenumOther diseases of intestines and peritoneumOther diseases of digestive systemDisorders of breastOther disorders of female genital tractOther inflammatory conditions of skin and subcutaneous tissueOther diseases of skin and subcutaneous tissueArthropathies and related disordersRheumatism, excluding the backOsteopathies, chondropathies, and acquired musculoskeletal deformitiesGeneral symptomsSymptoms involving respiratory system and other chest symptomsSymptoms involving digestive systemSymptoms involving urinary systemOther symptoms involving abdomen and pelvisDislocationNaCertain traumatic complications and unspecified injuriesRange name na----------------------------------------
Adrenergic alpha-1 Receptor Antagonists
Adrenergic beta-2 Receptor Agonists
Angiogenesis Inhibitors
Antacids
Anti-Allergic Agents
Anti-Asthmatic Agents
Anti-Bacterial Agents
Anti-Inflammatory Agents
Anti-Obesity Agents
Anti-Ulcer Agents
Antidepressive Agents, Second-Generation
Antidiarrheals
Antihypertensive Agents
Antimanic Agents
Antioxidants
Antipsychotic Agents
Aromatase Inhibitors
Bone Density Conservation Agents
Cyclooxygenase Inhibitors
Dopamine Antagonists
Dopamine Uptake Inhibitors
Estrogens
GABA Modulators
Glucocorticoids
Histamine H1 Antagonists
Histamine H1 Antagonists, Non-Sedating
Histamine H2 Antagonists
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypoglycemic Agents
Leukotriene Antagonists
Mineralocorticoid Receptor Antagonists
NA
Preservatives, Pharmaceutical
Progestins
Proton Pump Inhibitors
Serotonin 5-HT1 Receptor Agonists
Serotonin Uptake Inhibitors
Sodium Chloride Symporter Inhibitors
Trace Elements
Tubulin Modulators
Vitamin B Complex
Voltage-Gated Sodium Channel Blockers
===== phenotype 11=================================================================
proportion of pts: 0.231654105514
lambda: 8699.03990147
----------------------------------------
Viral diseases accompanied by exanthemMycosesMalignant neoplasm of skinNeoplasm of uncertain behavior of other sites & tissuesDisorders of thyroid glandDisorders of lipoid metabolismDisorders of the eye and adnexaDiseases of the ear and mastoid processHypertensive diseaseDiseases of veins and lymphatics, and other diseases of circulatory systemAcute respiratory infectionsOther diseases of the upper respiratory tractDiseases of esophagus, stomach, and duodenumInfections of skin and subcutaneous tissueOther inflammatory conditions of skin and subcutaneous tissueOther diseases of skin and subcutaneous tissueDorsopathiesRheumatism, excluding the backOsteopathies, chondropathies, and acquired musculoskeletal deformitiesCongenital anomaliesGeneral symptomsSymptoms involving digestive systemRange name na----------------------------------------
Adrenergic alpha-1 Receptor Antagonists
Adrenergic beta-1 Receptor Antagonists
Angiotensin II Type 1 Receptor Blockers
Antacids
Anti-Allergic Agents
Anti-Bacterial Agents
Antidepressive Agents, Second-Generation
Antifungal Agents
Antihypertensive Agents
Antimalarials
Antimanic Agents
Antineoplastic Agents, Hormonal
Bone Density Conservation Agents
Cyclooxygenase Inhibitors
Histamine H1 Antagonists, Non-Sedating
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypolipidemic Agents
Immunosuppressive Agents
NA
Narcotics
Nucleic Acid Synthesis Inhibitors
Proton Pump Inhibitors
Radiation-Protective Agents
Sodium Potassium Chloride Symporter Inhibitors
Tranquilizing Agents
Vasodilator Agents
Vitamin B Complex
Vitamins
===== phenotype 36=================================================================
proportion of pts: 0.195160650536
lambda: 8627.76879153
----------------------------------------
Intestinal infectious diseasesOperations on the eyeMalignant neoplasm of breastBenign neoplasm of other parts of digestive systemDisorders of fluid, electrolyte, and acid-base balanceAnemiasOrganic sleep disordersDisorders of the eye and adnexaDiseases of the ear and mastoid processHypertensive diseaseOther forms of heart diseaseAcute respiratory infectionsNoninfectious enteritis and colitisOther diseases of intestines and peritoneumLiverOther diseases of digestive systemNephritis, nephrotic syndrome, and nephrosisOther diseases of urinary systemDiseases of male genital organsArthropathies and related disordersOsteopathies, chondropathies, and acquired musculoskeletal deformitiesOperations on the musculoskeletal systemGeneral symptomsSymptoms involving cardiovascular systemSymptoms involving digestive systemSymptoms involving urinary systemOther symptoms involving abdomen and pelvisNonspecific findings on examination of urineNonspecific abnormal findings on radiological and other examination of body structureRange name na----------------------------------------
5-alpha Reductase Inhibitors
Adrenergic alpha-1 Receptor Antagonists
Adrenergic alpha-2 Receptor Agonists
Adrenergic beta-1 Receptor Antagonists
Analgesics, Non-Narcotic
Anesthetics, Intravenous
Antacids
Anti-Allergic Agents
Anti-Bacterial Agents
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Antidepressive Agents, Second-Generation
Antihypertensive Agents
Antimalarials
Antineoplastic Agents, Hormonal
Bone Density Conservation Agents
Cardiotonic Agents
Cathartics
Cholinergic Antagonists
Cyclooxygenase Inhibitors
Enzyme Inhibitors
GABA Modulators
GABA-A Receptor Agonists
Gastrointestinal Agents
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Immunosuppressive Agents
NA
Neuroprotective Agents
Nucleic Acid Synthesis Inhibitors
Parasympatholytics
Radiation-Sensitizing Agents
Rodenticides
Sodium Chloride Symporter Inhibitors
Sodium Potassium Chloride Symporter Inhibitors
Surface-Active Agents
Topoisomerase II Inhibitors
Trace Elements
Vasodilator Agents
Vitamin B Complex
Vitamins
===== phenotype 29=================================================================
proportion of pts: 0.168187227291
lambda: 8495.89160691
----------------------------------------
Other diseases due to viruses and chlamydiaeMalignant neoplasm of male and female genital organsDiseases of other endocrine glandsNutritional deficienciesDisorders of lipoid metabolismOverweight, obesity and other hyperalimentationOrganic sleep disordersDisorders of the eye and adnexaDiseases of the ear and mastoid processHypertensive diseaseIschemic heart diseaseOther forms of heart diseaseAcute respiratory infectionsOther diseases of the upper respiratory tractDiseases of esophagus, stomach, and duodenumHernia of abdominal cavityNoninfectious enteritis and colitisOther diseases of intestines and peritoneumDiseases of male genital organsOther diseases of skin and subcutaneous tissueArthropathies and related disordersDorsopathiesGeneral symptomsSymptoms involving skin and other integumentary tissueSymptoms involving cardiovascular systemSymptoms involving respiratory system and other chest symptomsNonspecific findings on examination of bloodRange name na----------------------------------------
5-alpha Reductase Inhibitors
Adrenergic alpha-1 Receptor Antagonists
Adrenergic beta-1 Receptor Antagonists
Anabolic Agents
Analgesics, Non-Narcotic
Androgens
Angiotensin II Type 1 Receptor Blockers
Anti-Allergic Agents
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Antidepressive Agents, Second-Generation
Antihypertensive Agents
Antimutagenic Agents
Bone Density Conservation Agents
Cyclooxygenase Inhibitors
Gastrointestinal Agents
Glucocorticoids
Histamine H1 Antagonists, Non-Sedating
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Immunosuppressive Agents
NA
Nucleic Acid Synthesis Inhibitors
Phosphodiesterase 5 Inhibitors
Platelet Aggregation Inhibitors
Proton Pump Inhibitors
Sodium Chloride Symporter Inhibitors
Sodium Potassium Chloride Symporter Inhibitors
Topoisomerase II Inhibitors
Tubulin Modulators
Vasodilator Agents
Vitamins
===== phenotype 24=================================================================
proportion of pts: 0.161840539468
lambda: 8461.33997049
----------------------------------------
Viral diseases accompanied by exanthemOther diseases due to viruses and chlamydiaeMycosesDisorders of thyroid glandDiabetesDisorders of lipoid metabolismAnemiasNaOther psychosesNeurotic, personality, nonpsychotic disordersDrug dependenceOrganic sleep disordersOther disorders of the central nervous systemDisorders of the eye and adnexaDiseases of the ear and mastoid processHypertensive diseaseOther forms of heart diseaseAcute respiratory infectionsOther diseases of the upper respiratory tractChronic obstructive pulmonary disease and allied conditionsDiseases of oral cavity, salivary glands, and jawsDiseases of esophagus, stomach, and duodenumOther diseases of intestines and peritoneumOther diseases of skin and subcutaneous tissueArthropathies and related disordersDorsopathiesRheumatism, excluding the backGeneral symptomsSymptoms involving head and neckSymptoms involving respiratory system and other chest symptomsSymptoms involving urinary systemOther symptoms involving abdomen and pelvisRange name na----------------------------------------
14-alpha Demethylase Inhibitors
Adrenergic Uptake Inhibitors
Adrenergic beta-1 Receptor Antagonists
Analgesics, Non-Narcotic
Anti-Allergic Agents
Anti-Bacterial Agents
Anti-Obesity Agents
Antidepressive Agents, Second-Generation
Antimanic Agents
Antipsychotic Agents
Antitussive Agents
Antiviral Agents
Calcium Channel Blockers
Cardiotonic Agents
Central Nervous System Depressants
Cholinergic Antagonists
Cyclooxygenase Inhibitors
Dermatologic Agents
Dopamine Antagonists
Dopamine Uptake Inhibitors
Expectorants
GABA Modulators
Histamine H1 Antagonists
Histamine H1 Antagonists, Non-Sedating
Histamine H2 Antagonists
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Immunosuppressive Agents
NA
Narcotics
Nasal Decongestants
Parasympatholytics
Proton Pump Inhibitors
Serotonin Uptake Inhibitors
Topoisomerase II Inhibitors
Vasoconstrictor Agents
Vasodilator Agents
Voltage-Gated Sodium Channel Blockers
===== phenotype 17=================================================================
proportion of pts: 0.215787385958
lambda: 8150.76322386
----------------------------------------
MycosesMalignant neoplasm of skinNeoplasm of uncertain behavior of other sites & tissuesDiabetesDisorders of lipoid metabolismHereditary and degenerative diseases of the central nervous systemDisorders of the eye and adnexaDiseases of the ear and mastoid processHypertensive diseaseDiseases of arteries, arterioles, and capillariesAcute respiratory infectionsOther diseases of the upper respiratory tractDiseases of male genital organsOther inflammatory conditions of skin and subcutaneous tissueOther diseases of skin and subcutaneous tissueArthropathies and related disordersDorsopathiesGeneral symptomsSymptoms involving head and neckSymptoms involving respiratory system and other chest symptomsAbnormal results of function studiesFracturesEffects of foreign body entering through orificeCertain traumatic complications and unspecified injuriesRange name na----------------------------------------
Adrenergic alpha-2 Receptor Agonists
Adrenergic beta-1 Receptor Antagonists
Analgesics, Non-Narcotic
Angiotensin II Type 1 Receptor Blockers
Anti-Allergic Agents
Anti-Bacterial Agents
Antidepressive Agents, Second-Generation
Antihypertensive Agents
Bone Density Conservation Agents
Cardiotonic Agents
Cyclooxygenase Inhibitors
Dipeptidyl-Peptidase IV Inhibitors
Enzyme Inhibitors
Expectorants
Explosive Agents
Free Radical Scavengers
GABA Modulators
Glucocorticoids
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypoglycemic Agents
Immunosuppressive Agents
Mineralocorticoid Receptor Antagonists
NA
Purinergic P2Y Receptor Antagonists
Sodium Chloride Symporter Inhibitors
Sodium Potassium Chloride Symporter Inhibitors
Surface-Active Agents
Topoisomerase II Inhibitors
Vasodilator Agents
===== phenotype 10=================================================================
proportion of pts: 0.144783815946
lambda: 8093.88696476
----------------------------------------
Other diseases due to viruses and chlamydiaeMalignant neoplasm of skinMalignant neoplasm of male and female genital organsBenign neoplasm of skinHemangioma and lymphangioma any siteNeoplasm of uncertain behavior of other sites & tissuesDiabetesNutritional deficienciesDisorders of lipoid metabolismGoutDisorders of fluid, electrolyte, and acid-base balanceCoagulation or hemorrhagic diseasesOther diseases of the bloodDisorders of the eye and adnexaHypertensive diseaseIschemic heart diseaseDiseases of veins and lymphatics, and other diseases of circulatory systemDiseases of esophagus, stomach, and duodenumNephritis, nephrotic syndrome, and nephrosisOther diseases of urinary systemInfections of skin and subcutaneous tissueOther inflammatory conditions of skin and subcutaneous tissueOther diseases of skin and subcutaneous tissueArthropathies and related disordersDorsopathiesRheumatism, excluding the backOsteopathies, chondropathies, and acquired musculoskeletal deformitiesGeneral symptomsSymptoms involving respiratory system and other chest symptomsSymptoms involving urinary systemOther symptoms involving abdomen and pelvisNonspecific findings on examination of bloodRange name na----------------------------------------
14-alpha Demethylase Inhibitors
5-alpha Reductase Inhibitors
Adrenergic alpha-1 Receptor Antagonists
Adrenergic alpha-2 Receptor Agonists
Adrenergic beta-1 Receptor Antagonists
Analgesics, Non-Narcotic
Androgens
Angiotensin II Type 1 Receptor Blockers
Anti-Allergic Agents
Anti-Bacterial Agents
Anti-Inflammatory Agents
Anticholesteremic Agents
Antihypertensive Agents
Antineoplastic Agents, Hormonal
Antitubercular Agents
Bone Density Conservation Agents
Carbonic Anhydrase Inhibitors
Cardiotonic Agents
Cathartics
Cyclooxygenase Inhibitors
Enzyme Inhibitors
Food Additives
Free Radical Scavengers
GABA-A Receptor Agonists
Gout Suppressants
Histamine H1 Antagonists, Non-Sedating
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypolipidemic Agents
Immunosuppressive Agents
Keratolytic Agents
NA
Nucleic Acid Synthesis Inhibitors
Ointment Bases
Phosphodiesterase 5 Inhibitors
Proton Pump Inhibitors
Rodenticides
Sodium Chloride Symporter Inhibitors
Sodium Potassium Chloride Symporter Inhibitors
Surface-Active Agents
Tubulin Modulators
Vasodilator Agents
Vitamin B Complex
Vitamins
Voltage-Gated Sodium Channel Blockers
===== phenotype 14=================================================================
proportion of pts: 0.192780642602
lambda: 7806.37964235
----------------------------------------
Malignant neoplasm of thyroid gland and other endocrine glands and related structuresBenign neoplasm of breast, ovary, uterus, and other genitourinary organsNeoplasms of unspecified natureDisorders of thyroid glandNutritional deficienciesDisorders of lipoid metabolismOverweight, obesity and other hyperalimentationOrganic sleep disordersHypertensive diseaseDiseases of veins and lymphatics, and other diseases of circulatory systemDiseases of oral cavity, salivary glands, and jawsLiverOther diseases of digestive systemDisorders of breastInflammatory disease of female pelvic organsOther disorders of female genital tractOperations on the female genital organsOperations on the musculoskeletal systemNonspecific findings on examination of bloodNonspecific abnormal findings on radiological and other examination of body structureRange name na----------------------------------------
14-alpha Demethylase Inhibitors
Adrenergic beta-1 Receptor Antagonists
Analgesics, Non-Narcotic
Angiotensin II Type 1 Receptor Blockers
Antacids
Anti-Allergic Agents
Anti-Bacterial Agents
Antidepressive Agents, Second-Generation
Antihypertensive Agents
Bone Density Conservation Agents
Cardiotonic Agents
Cyclooxygenase Inhibitors
Food Additives
GABA-A Receptor Agonists
Glucocorticoids
Histamine H1 Antagonists, Non-Sedating
Histamine H2 Antagonists
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypoglycemic Agents
Immunosuppressive Agents
NA
Narcotics
Nucleic Acid Synthesis Inhibitors
Proton Pump Inhibitors
Purinergic P1 Receptor Antagonists
Rodenticides
Sodium Chloride Symporter Inhibitors
Sodium Potassium Chloride Symporter Inhibitors
Surface-Active Agents
Topoisomerase II Inhibitors
Trace Elements
Tubulin Modulators
Vasodilator Agents
Vitamin B Complex
Vitamins
Voltage-Gated Sodium Channel Blockers
===== phenotype 9=================================================================
proportion of pts: 0.173343911146
lambda: 7391.53815522
----------------------------------------
Benign neoplasm of skinDisorders of thyroid glandDiabetesNutritional deficienciesDisorders of lipoid metabolismOverweight, obesity and other hyperalimentationNaNeurotic, personality, nonpsychotic disordersOther disorders of the central nervous systemDisorders of the eye and adnexaDiseases of the ear and mastoid processHypertensive diseaseIschemic heart diseaseOther forms of heart diseaseOther diseases of the upper respiratory tractOther disorders of female genital tractOther diseases of skin and subcutaneous tissueDorsopathiesCongenital anomaliesGeneral symptomsNaSymptoms involving nervous and musculoskeletal systemsSymptoms involving cardiovascular systemSymptoms involving respiratory system and other chest symptomsOther and unspecified effects of external causesRange name na----------------------------------------
Adrenergic alpha-1 Receptor Antagonists
Adrenergic beta-1 Receptor Antagonists
Analgesics, Non-Narcotic
Angiogenesis Inhibitors
Angiotensin II Type 1 Receptor Blockers
Anti-Allergic Agents
Antidepressive Agents, Second-Generation
Antihypertensive Agents
Antineoplastic Agents
Antioxidants
Bone Density Conservation Agents
Cardiotonic Agents
Cyclooxygenase 2 Inhibitors
Cyclooxygenase Inhibitors
Dopamine Uptake Inhibitors
Explosive Agents
GABA Modulators
GABA-A Receptor Agonists
Histamine H1 Antagonists, Non-Sedating
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypoglycemic Agents
Hypolipidemic Agents
Immunosuppressive Agents
Mineralocorticoid Receptor Antagonists
NA
Nootropic Agents
Proton Pump Inhibitors
Serotonin Receptor Agonists
Serotonin Uptake Inhibitors
Sodium Chloride Symporter Inhibitors
Sodium Potassium Chloride Symporter Inhibitors
Tranquilizing Agents
Vasodilator Agents
Vitamin B Complex
Vitamins
===== phenotype 13=================================================================
proportion of pts: 0.154303847679
lambda: 6021.93390783
----------------------------------------
Other bacterial diseasesArthropathies and related disordersRheumatism, excluding the backOsteopathies, chondropathies, and acquired musculoskeletal deformitiesFracturesDislocationSprains and strains of joints and adjacent musclesLate effects of injuries, poisonings, toxic effects, and other external causesNaCertain traumatic complications and unspecified injuries----------------------------------------
Adrenergic alpha-1 Receptor Antagonists
Adrenergic beta-1 Receptor Antagonists
Adrenergic beta-2 Receptor Agonists
Analgesics, Non-Narcotic
Angiotensin II Type 1 Receptor Blockers
Anti-Allergic Agents
Anti-Anxiety Agents
Anti-Bacterial Agents
Antidepressive Agents, Second-Generation
Antihypertensive Agents
Antimanic Agents
Bone Density Conservation Agents
Cardiotonic Agents
Cathartics
Cyclooxygenase Inhibitors
Estrogens
Explosive Agents
GABA Modulators
GABA-A Receptor Agonists
Histamine H1 Antagonists, Non-Sedating
Histamine H2 Antagonists
Hydroxymethylglutaryl-CoA Reductase Inhibitors
NA
Narcotics
Proton Pump Inhibitors
Rodenticides
Sodium Chloride Symporter Inhibitors
Sodium Potassium Chloride Symporter Inhibitors
Surface-Active Agents
Topoisomerase II Inhibitors
Vasodilator Agents
Vitamin B Complex
Vitamins
Voltage-Gated Sodium Channel Blockers
